{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:17:15Z","timestamp":1794374235255,"version":"4.9.0"},"reference-count":295,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institutes of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["R01AI181215"],"award-info":[{"award-number":["R01AI181215"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["R01AI181215"],"award-info":[{"award-number":["R01AI181215"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medicine","doi-asserted-by":"crossref","award":["P20GM113132"],"award-info":[{"award-number":["P20GM113132"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medicine","doi-asserted-by":"crossref","award":["P20GM113132"],"award-info":[{"award-number":["P20GM113132"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"crossref","award":["STANTO19R0"],"award-info":[{"award-number":["STANTO19R0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"crossref","award":["STANTO19R0"],"award-info":[{"award-number":["STANTO19R0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Antimicrob Resist"],"DOI":"10.1038\/s44259-025-00093-4","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T06:32:37Z","timestamp":1744439557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Targeting fungal lipid synthesis for antifungal drug development and potentiation of contemporary antifungals"],"prefix":"10.1038","volume":"3","author":[{"given":"Cecilia","family":"Gutierrez-Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,12]]},"reference":[{"key":"93_CR1","doi-asserted-by":"crossref","unstructured":"Denning, D. W. Global incidence and mortality of severe fungal disease. Lancet Infect Dis. 24, e428\u2013e438 (2024).","DOI":"10.1016\/S1473-3099(23)00692-8"},{"key":"93_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.15698\/mic2020.06.718","volume":"7","author":"K Kainz","year":"2020","unstructured":"Kainz, K. et al. Fungal infections in humans: the silent crisis. Micro. Cell 7, 143\u2013145 (2020).","journal-title":"Micro. Cell"},{"key":"93_CR3","doi-asserted-by":"publisher","first-page":"ofab593","DOI":"10.1093\/ofid\/ofab593","volume":"9","author":"E Rayens","year":"2022","unstructured":"Rayens, E. & Norris, K. A. Prevalence and healthcare burden of fungal infections in the United States, 2018. Open Forum Infect. Dis. 9, ofab593 (2022).","journal-title":"Open Forum Infect. Dis."},{"key":"93_CR4","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"Disease, G.B.D., I. Injury, and C.","year":"2017","unstructured":"Disease, G.B.D., I. Injury, and C. Prevalence, Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet 390, 1211\u20131259 (2017).","journal-title":"Lancet"},{"key":"93_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11046-016-0045-0","volume":"182","author":"AK Gupta","year":"2017","unstructured":"Gupta, A. K., Foley, K. A. & Versteeg, S. G. New antifungal agents and new formulations against dermatophytes. Mycopathologia 182, 127\u2013141 (2017).","journal-title":"Mycopathologia"},{"key":"93_CR6","doi-asserted-by":"publisher","first-page":"e00318","DOI":"10.1128\/AAC.00318-20","volume":"64","author":"Y Wu","year":"2020","unstructured":"Wu, Y. et al. Antifungal susceptibility profiles and drug resistance mechanisms of clinical lomentospora prolificans isolates. Antimicrob. Agents Chemother. 64, e00318\u2013e00320 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.mmcr.2016.04.005","volume":"11","author":"C Goldman","year":"2016","unstructured":"Goldman, C. et al. Scedosporium apiospermum infections and the role of combination antifungal therapy and GM-CSF: a case report and review of the literature. Med Mycol. Case Rep. 11, 40\u201343 (2016).","journal-title":"Med Mycol. Case Rep."},{"key":"93_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/mmy\/myx113","volume":"56","author":"A Ramirez-Garcia","year":"2018","unstructured":"Ramirez-Garcia, A. et al. Scedosporium and lomentospora: an updated overview of underrated opportunists. Med Mycol. 56, 102\u2013125 (2018).","journal-title":"Med Mycol."},{"key":"93_CR9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1128\/CMR.18.3.556-569.2005","volume":"18","author":"B Spellberg","year":"2005","unstructured":"Spellberg, B., Edwards, J. Jr. & Ibrahim, A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin. Microbiol Rev. 18, 556\u2013569 (2005).","journal-title":"Clin. Microbiol Rev."},{"key":"93_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1128\/CMR.12.1.40","volume":"12","author":"DJ Sheehan","year":"1999","unstructured":"Sheehan, D. J., Hitchcock, C. A. & Sibley, C. M. Current and emerging azole antifungal agents. Clin. Microbiol Rev. 12, 40\u201379 (1999).","journal-title":"Clin. Microbiol Rev."},{"key":"93_CR11","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1080\/14756366.2022.2050224","volume":"37","author":"M Szymanski","year":"2022","unstructured":"Szymanski, M. et al. Echinocandins - structure, mechanism of action and use in antifungal therapy. J. Enzym. Inhib. Med Chem. 37, 876\u2013894 (2022).","journal-title":"J. Enzym. Inhib. Med Chem."},{"key":"93_CR12","unstructured":"Padda, I. S. & Parmar, M. Flucytosine (StatPearls, 2024)."},{"key":"93_CR13","doi-asserted-by":"crossref","unstructured":"Rodrigues, M. L, The multifunctional fungal ergosterol. mBio. 9, e01755\u201318 (2019).","DOI":"10.1128\/mBio.01755-18"},{"key":"93_CR14","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.csbj.2021.03.013","volume":"19","author":"C Barata-Antunes","year":"2021","unstructured":"Barata-Antunes, C. et al. Endocytosis of nutrient transporters in fungi: The ART of connecting signaling and trafficking. Comput Struct. Biotechnol. J. 19, 1713\u20131737 (2021).","journal-title":"Comput Struct. Biotechnol. J."},{"key":"93_CR15","doi-asserted-by":"crossref","unstructured":"Van Dijck, P. et al. Nutrient sensing at the plasma membrane of fungal cells. Microbiol. Spectr. 5, 10.1128\/microbiolspec.funk-0031-2016 (2017).","DOI":"10.1128\/microbiolspec.FUNK-0031-2016"},{"key":"93_CR16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1146\/annurev-arplant-050312-120103","volume":"64","author":"J Malinsky","year":"2013","unstructured":"Malinsky, J. et al. Membrane microdomains, rafts, and detergent-resistant membranes in plants and fungi. Annu Rev. Plant Biol. 64, 501\u2013529 (2013).","journal-title":"Annu Rev. Plant Biol."},{"key":"93_CR17","doi-asserted-by":"publisher","first-page":"2299183","DOI":"10.1080\/21505594.2023.2299183","volume":"15","author":"Y Peng","year":"2024","unstructured":"Peng, Y. & Chen, B. Role of cell membrane homeostasis in the pathogenicity of pathogenic filamentous fungi. Virulence 15, 2299183 (2024).","journal-title":"Virulence"},{"key":"93_CR18","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/femsre\/fuz022","volume":"43","author":"A Athanasopoulos","year":"2019","unstructured":"Athanasopoulos, A. et al. Fungal plasma membrane domains. FEMS Microbiol. Rev. 43, 642\u2013673 (2019).","journal-title":"FEMS Microbiol. Rev."},{"key":"93_CR19","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1111\/jam.13301","volume":"121","author":"DG Sant","year":"2016","unstructured":"Sant, D. G. et al. Fungal cell membrane-promising drug target for antifungal therapy. J. Appl. Microbiol. 121, 1498\u20131510 (2016).","journal-title":"J. Appl. Microbiol."},{"key":"93_CR20","doi-asserted-by":"crossref","unstructured":"Zhukov, A. & Popov, E. Eukaryotic cell membranes: structure, composition, research methods and computational modelling. Int. J. Mol. Sci. 24, 11226 (2023).","DOI":"10.3390\/ijms241311226"},{"key":"93_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41579-022-00796-9","volume":"21","author":"NAR Gow","year":"2023","unstructured":"Gow, N. A. R. & Lenardon, M. D. Architecture of the dynamic fungal cell wall. Nat. Rev. Microbiol 21, 248\u2013259 (2023).","journal-title":"Nat. Rev. Microbiol"},{"key":"93_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.tim.2018.01.007","volume":"26","author":"A Hopke","year":"2018","unstructured":"Hopke, A. et al. Dynamic fungal cell wall architecture in stress adaptation and immune evasion. Trends Microbiol. 26, 284\u2013295 (2018).","journal-title":"Trends Microbiol."},{"key":"93_CR23","doi-asserted-by":"crossref","unstructured":"Brauer, V. S., et al. Chitin biosynthesis in aspergillus species. J. Fungi. (Basel). 9, (2023).","DOI":"10.3390\/jof9010089"},{"key":"93_CR24","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1111\/febs.14509","volume":"285","author":"S Tanaka","year":"2018","unstructured":"Tanaka, S. & Tani, M. Mannosylinositol phosphorylceramides and ergosterol coodinately maintain cell wall integrity in the yeast Saccharomyces cerevisiae. FEBS J. 285, 2405\u20132427 (2018).","journal-title":"FEBS J."},{"key":"93_CR25","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1128\/AAC.00597-13","volume":"57","author":"A Elefanti","year":"2013","unstructured":"Elefanti, A. et al. Amphotericin B- and voriconazole-echinocandin combinations against Aspergillus spp.: effect of serum on inhibitory and fungicidal interactions. Antimicrob. Agents Chemother. 57, 4656\u20134663 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1164\/rccm.200505-727SO","volume":"173","author":"BH Segal","year":"2006","unstructured":"Segal, B. H. & Walsh, T. J. Current approaches to diagnosis and treatment of invasive aspergillosis. Am. J. Respir. Crit. Care Med. 173, 707\u2013717 (2006).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"93_CR27","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa020191","volume":"347","author":"R Herbrecht","year":"2002","unstructured":"Herbrecht, R. et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N. Engl. J. Med. 347, 408\u2013415 (2002).","journal-title":"N. Engl. J. Med."},{"key":"93_CR28","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s40265-022-01757-5","volume":"82","author":"NTT Ngan","year":"2022","unstructured":"Ngan, N. T. T., Flower, B. & Day, J. N. Treatment of cryptococcal meningitis: how have we got here and where are we going? Drugs 82, 1237\u20131249 (2022).","journal-title":"Drugs"},{"key":"93_CR29","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3389\/fmicb.2018.01351","volume":"9","author":"GC de Oliveira Santos","year":"2018","unstructured":"de Oliveira Santos, G. C. et al. Candida infections and therapeutic strategies: mechanisms of action for traditional and alternative agents. Front Microbiol. 9, 1351 (2018).","journal-title":"Front Microbiol."},{"key":"93_CR30","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1146\/annurev-biochem-060409-092229","volume":"80","author":"GM Carman","year":"2011","unstructured":"Carman, G. M. & Han, G. S. Regulation of phospholipid synthesis in the yeast Saccharomyces cerevisiae. Annu Rev. Biochem. 80, 859\u2013883 (2011).","journal-title":"Annu Rev. Biochem."},{"key":"93_CR31","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1172\/JCI27890","volume":"116","author":"PC Rittershaus","year":"2006","unstructured":"Rittershaus, P. C. et al. Glucosylceramide synthase is an essential regulator of pathogenicity of cryptococcus neoformans. J. Clin. Invest 116, 1651\u20131659 (2006).","journal-title":"J. Clin. Invest"},{"key":"93_CR32","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1080\/14787210.2020.1792288","volume":"18","author":"C Mota Fernandes","year":"2020","unstructured":"Mota Fernandes, C. & Poeta, M. Del Fungal sphingolipids: role in the regulation of virulence and potential as targets for future antifungal therapies. Expert Rev. Anti Infect. Ther. 18, 1083\u20131092 (2020).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"93_CR33","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1128\/EC.00093-06","volume":"5","author":"K Piekarska","year":"2006","unstructured":"Piekarska, K. et al. Peroxisomal fatty acid beta-oxidation is not essential for virulence of Candida albicans. Eukaryot. Cell 5, 1847\u20131856 (2006).","journal-title":"Eukaryot. Cell"},{"key":"93_CR34","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1128\/EC.00128-12","volume":"11","author":"M Kretschmer","year":"2012","unstructured":"Kretschmer, M., Wang, J. & Kronstad, J. W. Peroxisomal and mitochondrial beta-oxidation pathways influence the virulence of the pathogenic fungus Cryptococcus neoformans. Eukaryot. Cell 11, 1042\u20131054 (2012).","journal-title":"Eukaryot. Cell"},{"key":"93_CR35","doi-asserted-by":"publisher","first-page":"e0168221","DOI":"10.1128\/mBio.01682-21","volume":"12","author":"LNA Ries","year":"2021","unstructured":"Ries, L. N. A. et al. Aspergillus fumigatus acetate utilization impacts virulence traits and pathogenicity. mBio 12, e0168221 (2021).","journal-title":"mBio"},{"key":"93_CR36","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3389\/fmicb.2015.00919","volume":"6","author":"S Mota","year":"2015","unstructured":"Mota, S. et al. Candida glabrata susceptibility to antifungals and phagocytosis is modulated by acetate. Front Microbiol. 6, 919 (2015).","journal-title":"Front Microbiol."},{"key":"93_CR37","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1111\/j.1365-2958.2008.06374.x","volume":"69","author":"G Hu","year":"2008","unstructured":"Hu, G. et al. Metabolic adaptation in Cryptococcus neoformans during early murine pulmonary infection. Mol. Microbiol 69, 1456\u20131475 (2008).","journal-title":"Mol. Microbiol"},{"key":"93_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1128\/EC.05273-11","volume":"11","author":"J Kronstad","year":"2012","unstructured":"Kronstad, J. et al. Adaptation of Cryptococcus neoformans to mammalian hosts: integrated regulation of metabolism and virulence. Eukaryot. Cell 11, 109\u2013118 (2012).","journal-title":"Eukaryot. Cell"},{"key":"93_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1128\/EC.00214-06","volume":"6","author":"A Idnurm","year":"2007","unstructured":"Idnurm, A. et al. Peroxisome function regulates growth on glucose in the basidiomycete fungus Cryptococcus neoformans. Eukaryot. Cell 6, 60\u201372 (2007).","journal-title":"Eukaryot. Cell"},{"key":"93_CR40","doi-asserted-by":"publisher","first-page":"5684","DOI":"10.1128\/IAI.70.10.5684-5694.2002","volume":"70","author":"TH Rude","year":"2002","unstructured":"Rude, T. H. et al. Relationship of the glyoxylate pathway to the pathogenesis of Cryptococcus neoformans. Infect. Immun. 70, 5684\u20135694 (2002).","journal-title":"Infect. Immun."},{"key":"93_CR41","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1111\/mmi.12065","volume":"86","author":"EJ Griffiths","year":"2012","unstructured":"Griffiths, E. J. et al. A defect in ATP-citrate lyase links acetyl-CoA production, virulence factor elaboration and virulence in Cryptococcus neoformans. Mol. Microbiol 86, 1404\u20131423 (2012).","journal-title":"Mol. Microbiol"},{"key":"93_CR42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/35083594","volume":"412","author":"MC Lorenz","year":"2001","unstructured":"Lorenz, M. C. & Fink, G. R. The glyoxylate cycle is required for fungal virulence. Nature 412, 83\u201386 (2001).","journal-title":"Nature"},{"key":"93_CR43","doi-asserted-by":"crossref","unstructured":"Brown, H. E. et al. Sterol-response pathways mediate alkaline survival in diverse fungi. mBio 11, e00719T.20 (2020).","DOI":"10.1128\/mBio.00719-20"},{"key":"93_CR44","doi-asserted-by":"publisher","first-page":"109542","DOI":"10.1016\/j.cellsig.2020.109542","volume":"68","author":"K Daicho","year":"2020","unstructured":"Daicho, K. et al. TORC1 ensures membrane trafficking of Tat2 tryptophan permease via a novel transcriptional activator Vhr2 in budding yeast. Cell Signal 68, 109542 (2020).","journal-title":"Cell Signal"},{"key":"93_CR45","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/s12275-022-1564-7","volume":"60","author":"N Long","year":"2022","unstructured":"Long, N. & Zhong, G. The C-22 sterol desaturase Erg5 is responsible for ergosterol biosynthesis and conidiation in Aspergillus fumigatus. J. Microbiol 60, 620\u2013626 (2022).","journal-title":"J. Microbiol"},{"key":"93_CR46","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/BF02536428","volume":"26","author":"C Chambon","year":"1991","unstructured":"Chambon, C. et al. Sterol pathway in yeast. Identification and properties of mutant strains defective in mevalonate diphosphate decarboxylase and farnesyl diphosphate synthetase. Lipids 26, 633\u2013636 (1991).","journal-title":"Lipids"},{"key":"93_CR47","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s12088-017-0657-1","volume":"57","author":"Z Hu","year":"2017","unstructured":"Hu, Z. et al. Recent advances in ergosterol biosynthesis and regulation mechanisms in Saccharomyces cerevisiae. Indian J. Microbiol. 57, 270\u2013277 (2017).","journal-title":"Indian J. Microbiol."},{"key":"93_CR48","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/molbev\/msq177","volume":"28","author":"J Lombard","year":"2011","unstructured":"Lombard, J. & Moreira, D. Origins and early evolution of the mevalonate pathway of isoprenoid biosynthesis in the three domains of life. Mol. Biol. Evol. 28, 87\u201399 (2011).","journal-title":"Mol. Biol. Evol."},{"key":"93_CR49","doi-asserted-by":"publisher","first-page":"5563","DOI":"10.1073\/pnas.83.15.5563","volume":"83","author":"ME Basson","year":"1986","unstructured":"Basson, M. E., Thorsness, M. & Rine, J. Saccharomyces cerevisiae contains two functional genes encoding 3-hydroxy-3-methylglutaryl-coenzyme a reductase. Proc. Natl Acad. Sci. USA 83, 5563\u20135567 (1986).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"93_CR50","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nature00935","volume":"418","author":"G Giaever","year":"2002","unstructured":"Giaever, G. et al. Functional profiling of the Saccharomyces cerevisiae genome. Nature 418, 387\u2013391 (2002).","journal-title":"Nature"},{"key":"93_CR51","first-page":"3888","volume":"1","author":"DC Aldridge","year":"1971","unstructured":"Aldridge, D. C., Giles, D. & Turner, W. B. Antibiotic 1233\u2009A: a fungal -lactone. J. Chem. Soc. Perkin 1, 3888\u20133891 (1971).","journal-title":"J. Chem. Soc. Perkin"},{"key":"93_CR52","doi-asserted-by":"publisher","first-page":"7488","DOI":"10.1073\/pnas.84.21.7488","volume":"84","author":"MD Greenspan","year":"1987","unstructured":"Greenspan, M. D. et al. Inhibition of hydroxymethylglutaryl-coenzyme a synthase by L-659,699. Proc. Natl Acad. Sci. USA 84, 7488\u20137492 (1987).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"93_CR53","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.molcel.2016.10.014","volume":"64","author":"J Fan","year":"2016","unstructured":"Fan, J. et al. Tetrameric acetyl-CoA acetyltransferase 1 is important for tumor growth. Mol. Cell 64, 859\u2013874 (2016).","journal-title":"Mol. Cell"},{"key":"93_CR54","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2460\/ajvr.1978.39.02.315","volume":"39","author":"KS Todd Jr.","year":"1978","unstructured":"Todd, K. S. Jr., Howland, T. P. & Woerpel, R. W. Activity of uredofos, niclosamide, bunamidine hydrochloride, and arecoline hydrobromide against Mesocestoides corti in experimentally infected dogs. Am. J. Vet. Res. 39, 315\u2013316 (1978).","journal-title":"Am. J. Vet. Res."},{"key":"93_CR55","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1371\/journal.ppat.0030024","volume":"3","author":"W Hu","year":"2007","unstructured":"Hu, W. et al. Essential gene identification and drug target prioritization in Aspergillus fumigatus. PLoS Pathog. 3, e24 (2007).","journal-title":"PLoS Pathog."},{"key":"93_CR56","doi-asserted-by":"crossref","unstructured":"Zhang, Y. et al. Aspergillus fumigatus mitochondrial acetyl coenzyme a acetyltransferase as an antifungal target. Appl. Environ. Microbiol. 86, e02986-19 (2020).","DOI":"10.1128\/AEM.02986-19"},{"key":"93_CR57","first-page":"454","volume":"5","author":"CC Lin","year":"2022","unstructured":"Lin, C. C. et al. Integrated omics approach to unveil antifungal bacterial polyynes as acetyl-CoA acetyltransferase inhibitors. Commun. Biol 5, 454 (2022).","journal-title":"Biol"},{"key":"93_CR58","doi-asserted-by":"publisher","first-page":"22044","DOI":"10.1073\/pnas.1009845107","volume":"107","author":"JM Becker","year":"2010","unstructured":"Becker, J. M. et al. Pathway analysis of Candida albicans survival and virulence determinants in a murine infection model. Proc. Natl Acad. Sci. USA 107, 22044\u201322049 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"93_CR59","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1128\/AAC.49.6.2226-2236.2005","volume":"49","author":"TT Liu","year":"2005","unstructured":"Liu, T. T. et al. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob. Agents Chemother. 49, 2226\u20132236 (2005).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR60","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00294-006-0073-2","volume":"50","author":"ME da Silva Ferreira","year":"2006","unstructured":"da Silva Ferreira, M. E. et al. Transcriptome analysis of Aspergillus fumigatus exposed to voriconazole. Curr. Genet 50, 32\u201344 (2006).","journal-title":"Curr. Genet"},{"key":"93_CR61","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1128\/AAC.01431-07","volume":"52","author":"P Gautam","year":"2008","unstructured":"Gautam, P. et al. Proteomic and transcriptomic analysis of Aspergillus fumigatus on exposure to amphotericin B. Antimicrob. Agents Chemother. 52, 4220\u20134227 (2008).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR62","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1471-2180-11-97","volume":"11","author":"AR Florio","year":"2011","unstructured":"Florio, A. R. et al. Genome-wide expression profiling of the response to short-term exposure to fluconazole in Cryptococcus neoformans serotype A. BMC Microbiol 11, 97 (2011).","journal-title":"BMC Microbiol"},{"key":"93_CR63","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrd1112","volume":"2","author":"JA Tobert","year":"2003","unstructured":"Tobert, J. A. Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors. Nat. Rev. Drug Discov. 2, 517\u2013526 (2003).","journal-title":"Nat. Rev. Drug Discov."},{"key":"93_CR64","doi-asserted-by":"publisher","first-page":"107483","DOI":"10.1016\/j.pharmthera.2020.107483","volume":"208","author":"A Tavakkoli","year":"2020","unstructured":"Tavakkoli, A., Johnston, T. P. & Sahebkar, A. Antifungal effects of statins. Pharm. Ther. 208, 107483 (2020).","journal-title":"Pharm. Ther."},{"key":"93_CR65","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev.genet.41.110306.130315","volume":"41","author":"PJ Espenshade","year":"2007","unstructured":"Espenshade, P. J. & Hughes, A. L. Regulation of sterol synthesis in eukaryotes. Annu Rev. Genet 41, 401\u2013427 (2007).","journal-title":"Annu Rev. Genet"},{"key":"93_CR66","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1128\/AAC.41.4.850","volume":"41","author":"NX Chin","year":"1997","unstructured":"Chin, N. X., Weitzman, I. & Della-Latta, P. In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans. Antimicrob. Agents Chemother. 41, 850\u2013852 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR67","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1574-6968.2010.01972.x","volume":"307","author":"I Nyilasi","year":"2010","unstructured":"Nyilasi, I. et al. In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi. FEMS Microbiol Lett. 307, 175\u2013184 (2010).","journal-title":"FEMS Microbiol Lett."},{"key":"93_CR68","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.biopha.2018.12.076","volume":"111","author":"WG Lima","year":"2019","unstructured":"Lima, W. G. et al. Are the Statins promising antifungal agents against invasive candidiasis? Biomed. Pharmacother. 111, 270\u2013281 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"93_CR69","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.plipres.2011.07.002","volume":"50","author":"JS Burg","year":"2011","unstructured":"Burg, J. S. & Espenshade, P. J. Regulation of HMG-CoA reductase in mammals and yeast. Prog. Lipid Res 50, 403\u2013410 (2011).","journal-title":"Prog. Lipid Res"},{"key":"93_CR70","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/13693780701397673","volume":"45","author":"J Qiao","year":"2007","unstructured":"Qiao, J. et al. Antifungal activity of statins against Aspergillus species. Med Mycol. 45, 589\u2013593 (2007).","journal-title":"Med Mycol."},{"key":"93_CR71","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1128\/AAC.50.1.96-103.2006","volume":"50","author":"G Chamilos","year":"2006","unstructured":"Chamilos, G., Lewis, R. E. & Kontoyiannis, D. P. Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole. Antimicrob. Agents Chemother. 50, 96\u2013103 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR72","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.bjid.2015.06.001","volume":"19","author":"RS Brilhante","year":"2015","unstructured":"Brilhante, R. S. et al. Simvastatin inhibits planktonic cells and biofilms of Candida and Cryptococcus species. Braz. J. Infect. Dis. 19, 459\u2013465 (2015).","journal-title":"Braz. J. Infect. Dis."},{"key":"93_CR73","doi-asserted-by":"crossref","unstructured":"Rybak, J. M., et al. Mutations in hmg1, challenging the paradigm of clinical triazole resistance in Aspergillus fumigatus. mBio 10, e00437T.19 (2019).","DOI":"10.1128\/mBio.00437-19"},{"key":"93_CR74","doi-asserted-by":"crossref","unstructured":"Gonzalez-Jimenez, I. et al. Are point mutations in HMG-CoA reductases (Hmg1 and Hmg2) a step towards azole resistance in Aspergillus fumigatus? Molecules 26, 5975 (2021).","DOI":"10.3390\/molecules26195975"},{"key":"93_CR75","doi-asserted-by":"crossref","unstructured":"Janik, A. et al. Synthesis of dolichols in Candida albicans is co-regulated with elongation of fatty acids. Int. J. Mol. Sci. 23, 409 (2021).","DOI":"10.3390\/ijms23010409"},{"key":"93_CR76","first-page":"113","volume":"7","author":"M Samoudi","year":"2015","unstructured":"Samoudi, M. et al. Inhibition of coenzyme Qs accumulation in engineered Escherichia coli by high concentration of farnesyl diphosphate. Avicenna J. Med. Biotechnol. 7, 113\u2013120 (2015).","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"93_CR77","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1021\/cb500791f","volume":"10","author":"CC Palsuledesai","year":"2015","unstructured":"Palsuledesai, C. C. & Distefano, M. D. Protein prenylation: enzymes, therapeutics, and biotechnology applications. ACS Chem. Biol. 10, 51\u201362 (2015).","journal-title":"ACS Chem. Biol."},{"key":"93_CR78","first-page":"620","volume":"11","author":"YH Tsay","year":"1991","unstructured":"Tsay, Y. H. & Robinson, G. W. Cloning and characterization of ERG8, an essential gene of Saccharomyces cerevisiae that encodes phosphomevalonate kinase. Mol. Cell Biol. 11, 620\u2013631 (1991).","journal-title":"Mol. Cell Biol."},{"key":"93_CR79","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0378-1119(90)90039-T","volume":"88","author":"A Oulmouden","year":"1990","unstructured":"Oulmouden, A. & Karst, F. Isolation of the ERG12 gene of Saccharomyces cerevisiae encoding mevalonate kinase. Gene 88, 253\u2013257 (1990).","journal-title":"Gene"},{"key":"93_CR80","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1128\/jb.179.15.4664-4670.1997","volume":"179","author":"T Berges","year":"1997","unstructured":"Berges, T., Guyonnet, D. & Karst, F. The Saccharomyces cerevisiae mevalonate diphosphate decarboxylase is essential for viability, and a single Leu-to-Pro mutation in a conserved sequence leads to thermosensitivity. J. Bacteriol. 179, 4664\u20134670 (1997).","journal-title":"J. Bacteriol."},{"key":"93_CR81","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/yea.320080907","volume":"8","author":"MP Mayer","year":"1992","unstructured":"Mayer, M. P. et al. Disruption and mapping of IDI1, the gene for isopentenyl diphosphate isomerase in Saccharomyces cerevisiae. Yeast 8, 743\u2013748 (1992).","journal-title":"Yeast"},{"key":"93_CR82","doi-asserted-by":"publisher","first-page":"e0024824","DOI":"10.1128\/msphere.00248-24","volume":"9","author":"A Kane","year":"2024","unstructured":"Kane, A. et al. Bisphosphonates synergistically enhance the antifungal activity of azoles in dermatophytes and other pathogenic molds. mSphere 9, e0024824 (2024).","journal-title":"mSphere"},{"key":"93_CR83","doi-asserted-by":"crossref","unstructured":"Hu, W., Jiang, B. & Roemer, T. Essential Genes in Aspergillus fumigatus, in Aspergillus fumigatus and Aspergillosis. p. 39-59 (2008).","DOI":"10.1128\/9781555815523.ch5"},{"key":"93_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50609-1","volume":"15","author":"H Elsaman","year":"2024","unstructured":"Elsaman, H. et al. Toxic eburicol accumulation drives the antifungal activity of azoles against Aspergillus fumigatus. Nat. Commun. 15, 6312 (2024).","journal-title":"Nat. Commun."},{"key":"93_CR85","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00253-021-11104-5","volume":"105","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. The sterol C-14 reductase Erg24 is responsible for ergosterol biosynthesis and ion homeostasis in Aspergillus fumigatus. Appl. Microbiol. Biotechnol. 105, 1253\u20131268 (2021).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"93_CR86","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1099\/mic.0.080440-0","volume":"160","author":"SJ Blosser","year":"2014","unstructured":"Blosser, S. J. et al. Two C4-sterol methyl oxidases (Erg25) catalyse ergosterol intermediate demethylation and impact environmental stress adaptation in Aspergillus fumigatus. Microbiol. (Read.) 160, 2492\u20132506 (2014).","journal-title":"Microbiol. (Read.)"},{"key":"93_CR87","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/jac\/dki112","volume":"55","author":"R Pasrija","year":"2005","unstructured":"Pasrija, R. et al. Squalene epoxidase encoded by ERG1 affects morphogenesis and drug susceptibilities of Candida albicans. J. Antimicrob. Chemother. 55, 905\u2013913 (2005).","journal-title":"J. Antimicrob. Chemother."},{"key":"93_CR88","doi-asserted-by":"publisher","first-page":"639","DOI":"10.7164\/antibiotics.45.639","volume":"45","author":"MJ Dawson","year":"1992","unstructured":"Dawson, M. J. et al. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity. J. Antibiot. (Tokyo) 45, 639\u2013647 (1992).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"93_CR89","doi-asserted-by":"publisher","first-page":"689","DOI":"10.7164\/antibiotics.46.689","volume":"46","author":"K Hasumi","year":"1993","unstructured":"Hasumi, K. et al. Competitive inhibition of squalene synthetase by squalestatin 1. J. Antibiot. (Tokyo) 46, 689\u2013691 (1993).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"93_CR90","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1126\/science.6547247","volume":"224","author":"G Petranyi","year":"1984","unstructured":"Petranyi, G., Ryder, N. S. & Stutz, A. Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase. Science 224, 1239\u20131241 (1984).","journal-title":"Science"},{"key":"93_CR91","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2165\/00003495-199549010-00008","volume":"49","author":"M Haria","year":"1995","unstructured":"Haria, M. & Bryson, H. M. Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections. Drugs 49, 103\u2013120 (1995).","journal-title":"Drugs"},{"key":"93_CR92","doi-asserted-by":"publisher","first-page":"104240","DOI":"10.1016\/j.bioorg.2020.104240","volume":"104","author":"M Shafiei","year":"2020","unstructured":"Shafiei, M. et al. History of the development of antifungal azoles: a review on structures, SAR, and mechanism of action. Bioorg. Chem. 104, 104240 (2020).","journal-title":"Bioorg. Chem."},{"key":"93_CR93","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1128\/CMR.1.2.187","volume":"1","author":"RA Fromtling","year":"1988","unstructured":"Fromtling, R. A. Overview of medically important antifungal azole derivatives. Clin. Microbiol Rev. 1, 187\u2013217 (1988).","journal-title":"Clin. Microbiol Rev."},{"key":"93_CR94","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/1120009X.1990.11738981","volume":"2","author":"K Richardson","year":"1990","unstructured":"Richardson, K. The discovery and profile of fluconazole. J. Chemother. 2, 51\u201354 (1990).","journal-title":"J. Chemother."},{"key":"93_CR95","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1128\/AAC.02770-15","volume":"60","author":"SR Lockhart","year":"2016","unstructured":"Lockhart, S. R. et al. The investigational fungal Cyp51 inhibitor VT-1129 demonstrates potent in vitro activity against Cryptococcus neoformans and cryptococcus gattii. Antimicrob. Agents Chemother. 60, 2528\u20132531 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR96","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/mmy\/myz092","volume":"58","author":"EP Garvey","year":"2020","unstructured":"Garvey, E. P. et al. The novel fungal CYP51 inhibitor VT-1598 displays classic dose-dependent antifungal activity in murine models of invasive aspergillosis. Med. Mycol. 58, 505\u2013513 (2020).","journal-title":"Med. Mycol."},{"key":"93_CR97","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1128\/AAC.02233-18","volume":"63","author":"NP Wiederhold","year":"2019","unstructured":"Wiederhold, N. P. et al. The fungal Cyp51-specific inhibitor VT-1598 demonstrates in vitro and in vivo activity against Candida auris. Antimicrob. Agents Chemother. 63, 3 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR98","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1016\/j.bmcl.2014.05.068","volume":"24","author":"WJ Hoekstra","year":"2014","unstructured":"Hoekstra, W. J. et al. Design and optimization of highly-selective fungal CYP51 inhibitors. Bioorg. Med Chem. Lett. 24, 3455\u20133458 (2014).","journal-title":"Bioorg. Med Chem. Lett."},{"key":"93_CR99","doi-asserted-by":"crossref","unstructured":"Ahmad, S. et al. ERG6 and ERG2 are major targets conferring reduced susceptibility to amphotericin B in clinical Candida glabrata isolates in Kuwait. Antimicrob Agents Chemother. 63, e01900\u201318 (2019).","DOI":"10.1128\/AAC.01900-18"},{"key":"93_CR100","doi-asserted-by":"crossref","unstructured":"Long, N. et al. Erg4A and Erg4B are required for conidiation and azole resistance via regulation of ergosterol biosynthesis in Aspergillus fumigatus. Appl. Environ. Microbiol. 83, e02924\u201316 (2017).","DOI":"10.1128\/AEM.02924-16"},{"key":"93_CR101","doi-asserted-by":"publisher","first-page":"e0031123","DOI":"10.1128\/msphere.00311-23","volume":"8","author":"JB Gregor","year":"2023","unstructured":"Gregor, J. B. et al. An expanded toolkit of drug resistance cassettes for Candida glabrata, Candida auris, and Candida albicans leads to new insights into the ergosterol pathway. mSphere 8, e0031123 (2023).","journal-title":"mSphere"},{"key":"93_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48767-3","volume":"15","author":"J Xie","year":"2024","unstructured":"Xie, J. et al. The sterol C-24 methyltransferase encoding gene, erg6, is essential for viability of Aspergillus species. Nat. Commun. 15, 4261 (2024).","journal-title":"Nat. Commun."},{"key":"93_CR103","doi-asserted-by":"publisher","first-page":"103368","DOI":"10.1016\/j.fgb.2020.103368","volume":"140","author":"FFM Oliveira","year":"2020","unstructured":"Oliveira, F. F. M. et al. Erg6 affects membrane composition and virulence of the human fungal pathogen Cryptococcus neoformans. Fungal Genet Biol. 140, 103368 (2020).","journal-title":"Fungal Genet Biol."},{"key":"93_CR104","first-page":"553","volume":"30","author":"X Jin","year":"2023","unstructured":"Jin, X. et al. Characterization of an allosteric inhibitor of fungal-specific C-24 sterol methyltransferase to treat Candida albicans infections. Cell. Chem. Biol. 30, 553\u2013568.e7 (2023).","journal-title":"Chem. Biol."},{"key":"93_CR105","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1021\/acsinfecdis.2c00490","volume":"9","author":"Z Liu","year":"2023","unstructured":"Liu, Z. et al. Biosensor-enabled discovery of CaERG6 inhibitors and their antifungal mode of action against Candida albicans. ACS Infect. Dis. 9, 785\u2013800 (2023).","journal-title":"ACS Infect. Dis."},{"key":"93_CR106","doi-asserted-by":"crossref","unstructured":"Bohner, F., Papp, C. & Gacser, A. The effect of antifungal resistance development on the virulence of Candida species. FEMS Yeast Res. 22, foac019 (2022).","DOI":"10.1093\/femsyr\/foac019"},{"key":"93_CR107","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1128\/EC.00116-15","volume":"14","author":"A Luna-Tapia","year":"2015","unstructured":"Luna-Tapia, A. et al. ERG2 and ERG24 are required for normal vacuolar physiology as well as Candida albicans pathogenicity in a murine model of disseminated but not vaginal candidiasis. Eukaryot. Cell 14, 1006\u20131016 (2015).","journal-title":"Eukaryot. Cell"},{"key":"93_CR108","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00249-014-0983-8","volume":"43","author":"DM Kaminski","year":"2014","unstructured":"Kaminski, D. M. Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments. Eur. Biophys. J. 43, 453\u2013467 (2014).","journal-title":"Eur. Biophys. J."},{"key":"93_CR109","doi-asserted-by":"crossref","unstructured":"Carolus, H. et al. Amphotericin B and other polyenes-discovery, clinical use, mode of action and drug resistance. J. Fungi (Basel). 6, 321 (2020).","DOI":"10.3390\/jof6040321"},{"key":"93_CR110","doi-asserted-by":"publisher","first-page":"e1001692","DOI":"10.1371\/journal.pbio.1001692","volume":"11","author":"BM Vincent","year":"2013","unstructured":"Vincent, B. M. et al. Fitness trade-offs restrict the evolution of resistance to amphotericin B. PLoS Biol. 11, e1001692 (2013).","journal-title":"PLoS Biol."},{"key":"93_CR111","doi-asserted-by":"publisher","first-page":"e0005322","DOI":"10.1128\/aac.00053-22","volume":"66","author":"SE Jacobs","year":"2022","unstructured":"Jacobs, S. E. et al. Candida auris pan-drug-resistant to four classes of antifungal agents. Antimicrob. Agents Chemother. 66, e0005322 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR112","doi-asserted-by":"publisher","first-page":"e0227621","DOI":"10.1128\/aac.02276-21","volume":"66","author":"R Shivarathri","year":"2022","unstructured":"Shivarathri, R. et al. Comparative transcriptomics reveal possible mechanisms of amphotericin B resistance in Candida auris. Antimicrob. Agents Chemother. 66, e0227621 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR113","doi-asserted-by":"crossref","unstructured":"Carolus, H. et al. Genome-wide analysis of experimentally evolved Candida auris reveals multiple novel mechanisms of multidrug resistance. mBio 12, e03333\u201320 (2021).","DOI":"10.1128\/mBio.03333-20"},{"key":"93_CR114","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.cmi.2021.11.024","volume":"28","author":"JM Rybak","year":"2022","unstructured":"Rybak, J. M. et al. In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris. Clin. Microbiol. Infect. 28, 838\u2013843 (2022).","journal-title":"Clin. Microbiol. Infect."},{"key":"93_CR115","doi-asserted-by":"publisher","first-page":"S445","DOI":"10.1093\/infdis\/jix131","volume":"216","author":"MC Arendrup","year":"2017","unstructured":"Arendrup, M. C. & Patterson, T. F. Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment. J. Infect. Dis. 216, S445\u2013S451 (2017).","journal-title":"J. Infect. Dis."},{"key":"93_CR116","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1128\/AAC.47.8.2404-2412.2003","volume":"47","author":"D Sanglard","year":"2003","unstructured":"Sanglard, D. et al. Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob. Agents Chemother. 47, 2404\u20132412 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR117","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1128\/AAC.47.9.2717-2724.2003","volume":"47","author":"LY Young","year":"2003","unstructured":"Young, L. Y., Hull, C. M. & Heitman, J. Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae. Antimicrob. Agents Chemother. 47, 2717\u20132724 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR118","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1574-6968.1994.tb07140.x","volume":"122","author":"SL Kelly","year":"1994","unstructured":"Kelly, S. L. et al. Resistance to amphotericin B associated with defective sterol delta 8\u2013\u2009>\u20097 isomerase in a Cryptococcus neoformans strain from an AIDS patient. FEMS Microbiol. Lett. 122, 39\u201342 (1994).","journal-title":"FEMS Microbiol. Lett."},{"key":"93_CR119","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/cid\/ciy411","volume":"68","author":"P Escandon","year":"2019","unstructured":"Escandon, P. et al. Molecular epidemiology of Candida auris in Colombia reveals a highly related, countrywide colonization with regional patterns in amphotericin B resistance. Clin. Infect. Dis. 68, 15\u201321 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"93_CR120","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","volume":"10","author":"FB Cavassin","year":"2021","unstructured":"Cavassin, F. B. et al. Sixty years of amphotericin B: an overview of the main antifungal agent used to treat invasive fungal infections. Infect. Dis. Ther. 10, 115\u2013147 (2021).","journal-title":"Infect. Dis. Ther."},{"key":"93_CR121","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","volume":"76","author":"NR Stone","year":"2016","unstructured":"Stone, N. R. et al. Liposomal amphotericin B (AmBisome((R))): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions. Drugs 76, 485\u2013500 (2016).","journal-title":"Drugs"},{"key":"93_CR122","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s41586-023-06710-4","volume":"623","author":"A Maji","year":"2023","unstructured":"Maji, A. et al. Tuning sterol extraction kinetics yields a renal-sparing polyene antifungal. Nature 623, 1079\u20131085 (2023).","journal-title":"Nature"},{"key":"93_CR123","doi-asserted-by":"publisher","first-page":"2161671","DOI":"10.1080\/10717544.2022.2161671","volume":"30","author":"X Zhong","year":"2023","unstructured":"Zhong, X. et al. Potential lipid-based strategies of amphotericin B designed for oral administration in clinical application. Drug Deliv. 30, 2161671 (2023).","journal-title":"Drug Deliv."},{"key":"93_CR124","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1021\/acs.molpharmaceut.9b00662","volume":"16","author":"K Thanki","year":"2019","unstructured":"Thanki, K., Date, T. & Jain, S. Improved oral bioavailability and gastrointestinal stability of amphotericin B through fatty acid conjugation approach. Mol. Pharm. 16, 4519\u20134529 (2019).","journal-title":"Mol. Pharm."},{"key":"93_CR125","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1093\/cid\/ciad440","volume":"77","author":"DR Boulware","year":"2023","unstructured":"Boulware, D. R. et al. Oral lipid nanocrystal amphotericin B for cryptococcal meningitis: a randomized clinical trial. Clin. Infect. Dis. 77, 1659\u20131667 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"93_CR126","first-page":"597","volume":"8","author":"S Qiu","year":"2015","unstructured":"Qiu, S. et al. Natamycin in the treatment of fungal keratitis: a systematic review and Meta-analysis. Int J. Ophthalmol. 8, 597\u2013602 (2015).","journal-title":"Int J. Ophthalmol."},{"key":"93_CR127","doi-asserted-by":"publisher","first-page":"30981","DOI":"10.1074\/jbc.M109.024752","volume":"284","author":"J Petschnigg","year":"2009","unstructured":"Petschnigg, J. et al. Good fat, essential cellular requirements for triacylglycerol synthesis to maintain membrane homeostasis in yeast. J. Biol. Chem. 284, 30981\u201330993 (2009).","journal-title":"J. Biol. Chem."},{"key":"93_CR128","doi-asserted-by":"publisher","first-page":"30994","DOI":"10.1074\/jbc.M109.050443","volume":"284","author":"J Garbarino","year":"2009","unstructured":"Garbarino, J. et al. Sterol and diacylglycerol acyltransferase deficiency triggers fatty acid-mediated cell death. J. Biol. Chem. 284, 30994\u201331005 (2009).","journal-title":"J. Biol. Chem."},{"key":"93_CR129","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.bbrc.2004.05.076","volume":"319","author":"KY Kim","year":"2004","unstructured":"Kim, K. Y. et al. Molecular cloning and biochemical characterization of Candida albicans acyl-CoA:sterol acyltransferase, a potential target of antifungal agents. Biochem Biophys. Res Commun. 319, 911\u2013919 (2004).","journal-title":"Biochem Biophys. Res Commun."},{"key":"93_CR130","doi-asserted-by":"publisher","first-page":"10946","DOI":"10.1016\/S0021-9258(18)82077-4","volume":"268","author":"M Hasslacher","year":"1993","unstructured":"Hasslacher, M. et al. Acetyl-CoA carboxylase from yeast is an essential enzyme and is regulated by factors that control phospholipid metabolism. J. Biol. Chem. 268, 10946\u201310952 (1993).","journal-title":"J. Biol. Chem."},{"key":"93_CR131","doi-asserted-by":"publisher","first-page":"12315","DOI":"10.1016\/S0021-9258(18)37757-3","volume":"263","author":"AH Mohamed","year":"1988","unstructured":"Mohamed, A. H. et al. Primary structure of the multifunctional alpha subunit protein of yeast fatty acid synthase derived from FAS2 gene sequence. J. Biol. Chem. 263, 12315\u201312325 (1988).","journal-title":"J. Biol. Chem."},{"key":"93_CR132","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1016\/S0021-9258(17)34743-9","volume":"253","author":"JK Stoops","year":"1978","unstructured":"Stoops, J. K. et al. Studies on the yeast fatty acid synthetase. Subunit composition and structural organization of a large multifunctional enzyme complex. J. Biol. Chem. 253, 4464\u20134475 (1978).","journal-title":"J. Biol. Chem."},{"key":"93_CR133","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.sbi.2008.09.008","volume":"18","author":"M Leibundgut","year":"2008","unstructured":"Leibundgut, M. et al. The multienzyme architecture of eukaryotic fatty acid synthases. Curr. Opin. Struct. Biol. 18, 714\u2013725 (2008).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"93_CR134","doi-asserted-by":"publisher","first-page":"16537","DOI":"10.1016\/S0021-9258(19)84740-3","volume":"264","author":"JE Stukey","year":"1989","unstructured":"Stukey, J. E., McDonough, V. M. & Martin, C. E. Isolation and characterization of OLE1, a gene affecting fatty acid desaturation from Saccharomyces cerevisiae. J. Biol. Chem. 264, 16537\u201316544 (1989).","journal-title":"J. Biol. Chem."},{"key":"93_CR135","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.chemphyslip.2007.06.213","volume":"150","author":"K Hac-Wydro","year":"2007","unstructured":"Hac-Wydro, K. & Wydro, P. The influence of fatty acids on model cholesterol\/phospholipid membranes. Chem. Phys. Lipids 150, 66\u201381 (2007).","journal-title":"Chem. Phys. Lipids"},{"key":"93_CR136","doi-asserted-by":"publisher","first-page":"e107966","DOI":"10.15252\/embj.2021107966","volume":"40","author":"X Bao","year":"2021","unstructured":"Bao, X. et al. Shortening of membrane lipid acyl chains compensates for phosphatidylcholine deficiency in choline-auxotroph yeast. EMBO J. 40, e107966 (2021).","journal-title":"EMBO J."},{"key":"93_CR137","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1091\/mbc.e08-11-1126","volume":"20","author":"XL Guan","year":"2009","unstructured":"Guan, X. L. et al. Functional interactions between sphingolipids and sterols in biological membranes regulating cell physiology. Mol. Biol. Cell 20, 2083\u20132095 (2009).","journal-title":"Mol. Biol. Cell"},{"key":"93_CR138","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1128\/EC.00138-14","volume":"13","author":"MD Leach","year":"2014","unstructured":"Leach, M. D. & Cowen, L. E. Membrane fluidity and temperature sensing are coupled via circuitry comprised of Ole1, Rsp5, and Hsf1 in Candida albicans. Eukaryot. Cell 13, 1077\u20131084 (2014).","journal-title":"Eukaryot. Cell"},{"key":"93_CR139","doi-asserted-by":"publisher","first-page":"18413","DOI":"10.1074\/jbc.271.31.18413","volume":"271","author":"DA Toke","year":"1996","unstructured":"Toke, D. A. & Martin, C. E. Isolation and characterization of a gene affecting fatty acid elongation in Saccharomyces cerevisiae. J. Biol. Chem. 271, 18413\u201318422 (1996).","journal-title":"J. Biol. Chem."},{"key":"93_CR140","doi-asserted-by":"publisher","first-page":"17376","DOI":"10.1074\/jbc.272.28.17376","volume":"272","author":"CS Oh","year":"1997","unstructured":"Oh, C. S. et al. ELO2 and ELO3, homologues of the Saccharomyces cerevisiae ELO1 gene, function in fatty acid elongation and are required for sphingolipid formation. J. Biol. Chem. 272, 17376\u201317384 (1997).","journal-title":"J. Biol. Chem."},{"key":"93_CR141","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1128\/AAC.05663-11","volume":"56","author":"T Xu","year":"2012","unstructured":"Xu, T. et al. A potent plant-derived antifungal acetylenic acid mediates its activity by interfering with fatty acid homeostasis. Antimicrob. Agents Chemother. 56, 2894\u20132907 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR142","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1083\/jcb.127.3.751","volume":"127","author":"DR Johnson","year":"1994","unstructured":"Johnson, D. R. et al. Saccharomyces cerevisiae contains four fatty acid activation (FAA) genes: an assessment of their role in regulating protein N-myristoylation and cellular lipid metabolism. J. Cell Biol. 127, 751\u2013762 (1994).","journal-title":"J. Cell Biol."},{"key":"93_CR143","doi-asserted-by":"publisher","first-page":"37051","DOI":"10.1074\/jbc.M100884200","volume":"276","author":"NJ Faergeman","year":"2001","unstructured":"Faergeman, N. J. et al. The Acyl-CoA synthetases encoded within FAA1 and FAA4 in Saccharomyces cerevisiae function as components of the fatty acid transport system linking import, activation, and intracellular Utilization. J. Biol. Chem. 276, 37051\u201337059 (2001).","journal-title":"J. Biol. Chem."},{"key":"93_CR144","doi-asserted-by":"publisher","first-page":"105419","DOI":"10.1016\/j.micpath.2022.105419","volume":"164","author":"XH Li","year":"2022","unstructured":"Li, X. H. et al. A homologue of yeast acyl-CoA synthetase Faa1 contributes to cytomembrane functionality involved in development and virulence in the insect pathogenic fungus Beauveria bassiana. Micro. Pathog. 164, 105419 (2022).","journal-title":"Micro. Pathog."},{"key":"93_CR145","doi-asserted-by":"crossref","unstructured":"Tenagy, et al. Long-chain Acyl-CoA synthetase is associated with the growth of malassezia spp. J. Fungi (Basel). 5, 8 (2019).","DOI":"10.3390\/jof5040088"},{"key":"93_CR146","doi-asserted-by":"publisher","first-page":"e0113123","DOI":"10.1128\/aac.01131-23","volume":"68","author":"T Chen","year":"2024","unstructured":"Chen, T. et al. Repurposing a human acetyl-CoA carboxylase inhibitor firsocostat to treat fungal candidiasis alone and in combination. Antimicrob. Agents Chemother. 68, e0113123 (2024).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR147","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/BF00309532","volume":"25","author":"HF Vahlensieck","year":"1994","unstructured":"Vahlensieck, H. F. et al. Identification of the yeast ACC1 gene product (acetyl-CoA carboxylase) as the target of the polyketide fungicide soraphen A. Curr. Genet 25, 95\u2013100 (1994).","journal-title":"Curr. Genet"},{"key":"93_CR148","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.bcp.2010.12.014","volume":"81","author":"DB Jump","year":"2011","unstructured":"Jump, D. B., Torres-Gonzalez, M. & Olson, L. K. Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation. Biochem Pharm. 81, 649\u2013660 (2011).","journal-title":"Biochem Pharm."},{"key":"93_CR149","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s002940050410","volume":"34","author":"J Morrice","year":"1998","unstructured":"Morrice, J. et al. Isolation and characterisation of the acetyl-CoA carboxylase gene from Aspergillus nidulans. Curr. Genet 34, 379\u2013385 (1998).","journal-title":"Curr. Genet"},{"key":"93_CR150","doi-asserted-by":"publisher","first-page":"7115","DOI":"10.1128\/AAC.01061-16","volume":"60","author":"K Koselny","year":"2016","unstructured":"Koselny, K. et al. The celecoxib derivative AR-12 has broad-spectrum antifungal activity in vitro and improves the activity of fluconazole in a murine model of Cryptococcosis. Antimicrob. Agents Chemother. 60, 7115\u20137127 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR151","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1021\/acsinfecdis.5b00134","volume":"2","author":"K Koselny","year":"2016","unstructured":"Koselny, K. et al. Antitumor\/antifungal celecoxib derivative AR-12 is a non-nucleoside inhibitor of the ANL-family adenylating enzyme acetyl CoA synthetase. ACS Infect. Dis. 2, 268\u2013280 (2016).","journal-title":"ACS Infect. Dis."},{"key":"93_CR152","doi-asserted-by":"publisher","first-page":"631","DOI":"10.4161\/cib.17446","volume":"4","author":"LN Nguyen","year":"2011","unstructured":"Nguyen, L. N. & Nosanchuk, J. D. The inhibitory effect of cerulenin to yeasts is fungicidal. Commun. Integr. Biol. 4, 631\u2013632 (2011).","journal-title":"Commun. Integr. Biol."},{"key":"93_CR153","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.chembiol.2023.06.005","volume":"30","author":"KR Iyer","year":"2023","unstructured":"Iyer, K. R. et al. Identification of triazenyl indoles as inhibitors of fungal fatty acid biosynthesis with broad-spectrum activity. Cell Chem. Biol. 30, 795\u2013810.e8 (2023).","journal-title":"Cell Chem. Biol."},{"key":"93_CR154","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1128\/AAC.00442-07","volume":"51","author":"M Chayakulkeeree","year":"2007","unstructured":"Chayakulkeeree, M. et al. Fatty acid synthesis is essential for survival of Cryptococcus neoformans and a potential fungicidal target. Antimicrob. Agents Chemother. 51, 3537\u20133545 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR155","doi-asserted-by":"publisher","first-page":"e8421","DOI":"10.1371\/journal.pone.0008421","volume":"4","author":"LN Nguyen","year":"2009","unstructured":"Nguyen, L. N., Trofa, D. & Nosanchuk, J. D. Fatty acid synthase impacts the pathobiology of Candida parapsilosis in vitro and during mammalian infection. PLoS One 4, e8421 (2009).","journal-title":"PLoS One"},{"key":"93_CR156","doi-asserted-by":"publisher","first-page":"14873","DOI":"10.1073\/pnas.93.25.14873","volume":"93","author":"DW Brown","year":"1996","unstructured":"Brown, D. W., Adams, T. H. & Keller, N. P. Aspergillus has distinct fatty acid synthases for primary and secondary metabolism. Proc. Natl Acad. Sci. USA 93, 14873\u201314877 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"93_CR157","doi-asserted-by":"publisher","first-page":"e0162723","DOI":"10.1128\/spectrum.01627-23","volume":"11","author":"J Fabri","year":"2023","unstructured":"Fabri, J. et al. The heat shock transcription factor HsfA plays a role in membrane lipids biosynthesis connecting thermotolerance and unsaturated fatty acid metabolism in Aspergillus fumigatus. Microbiol Spectr. 11, e0162723 (2023).","journal-title":"Microbiol Spectr."},{"key":"93_CR158","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1099\/mic.0.27029-0","volume":"150","author":"S Krishnamurthy","year":"2004","unstructured":"Krishnamurthy, S. et al. Dosage-dependent functions of fatty acid desaturase Ole1p in growth and morphogenesis of Candida albicans. Microbiol. (Read.) 150, 1991\u20132003 (2004).","journal-title":"Microbiol. (Read.)"},{"key":"93_CR159","doi-asserted-by":"crossref","unstructured":"Segal, E. S. et al. Gene essentiality analyzed by in vivo transposon mutagenesis and machine learning in a stable haploid Isolate of Candida albicans. mBio 9, e02048\u201318 (2018).","DOI":"10.1128\/mBio.02048-18"},{"key":"93_CR160","doi-asserted-by":"publisher","first-page":"e0116624","DOI":"10.1128\/mbio.01166-24","volume":"15","author":"C Gutierrez-Perez","year":"2024","unstructured":"Gutierrez-Perez, C. et al. Unsaturated fatty acid perturbation combats emerging triazole antifungal resistance in the human fungal pathogen Aspergillus fumigatus. mBio 15, e0116624 (2024).","journal-title":"mBio"},{"key":"93_CR161","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.1021\/jm401516c","volume":"57","author":"Z Zhang","year":"2014","unstructured":"Zhang, Z., Dales, N. A. & Winther, M. D. Opportunities and challenges in developing stearoyl-coenzyme a desaturase-1 inhibitors as novel therapeutics for human disease. J. Med Chem. 57, 5039\u20135056 (2014).","journal-title":"J. Med Chem."},{"key":"93_CR162","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1128\/AAC.01443-13","volume":"58","author":"P Knechtle","year":"2014","unstructured":"Knechtle, P. et al. The natural diyne-furan fatty acid EV-086 is an inhibitor of fungal delta-9 fatty acid desaturation with efficacy in a model of skin dermatophytosis. Antimicrob. Agents Chemother. 58, 455\u2013466 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR163","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1021\/acsinfecdis.1c00404","volume":"7","author":"C DeJarnette","year":"2021","unstructured":"DeJarnette, C. et al. Identification of inhibitors of fungal fatty acid biosynthesis. ACS Infect. Dis. 7, 3210\u20133223 (2021).","journal-title":"ACS Infect. Dis."},{"key":"93_CR164","doi-asserted-by":"publisher","first-page":"1434939","DOI":"10.3389\/fcimb.2024.1434939","volume":"14","author":"F Tebbji","year":"2024","unstructured":"Tebbji, F. et al. Small molecule inhibitors of fungal Delta(9) fatty acid desaturase as antifungal agents against Candida auris. Front Cell Infect. Microbiol 14, 1434939 (2024).","journal-title":"Front Cell Infect. Microbiol"},{"key":"93_CR165","doi-asserted-by":"publisher","first-page":"4718","DOI":"10.1128\/MCB.17.8.4718","volume":"17","author":"S Zhang","year":"1997","unstructured":"Zhang, S. et al. Genetic redundancy between SPT23 and MGA2: regulators of Ty-induced mutations and Ty1 transcription in Saccharomyces cerevisiae. Mol. Cell Biol. 17, 4718\u20134729 (1997).","journal-title":"Mol. Cell Biol."},{"key":"93_CR166","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/genetics\/151.2.473","volume":"151","author":"S Zhang","year":"1999","unstructured":"Zhang, S., Skalsky, Y. & Garfinkel, D. J. MGA2 or SPT23 is required for transcription of the delta9 fatty acid desaturase gene, OLE1, and nuclear membrane integrity in Saccharomyces cerevisiae. Genetics 151, 473\u2013483 (1999).","journal-title":"Genetics"},{"key":"93_CR167","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0092-8674(00)00080-5","volume":"102","author":"T Hoppe","year":"2000","unstructured":"Hoppe, T. et al. Activation of a membrane-bound transcription factor by regulated ubiquitin\/proteasome-dependent processing. Cell 102, 577\u2013586 (2000).","journal-title":"Cell"},{"key":"93_CR168","doi-asserted-by":"crossref","unstructured":"du Plooy, L. M. et al. A fungal ubiquitin ligase and arrestin binding partner contribute to pathogenesis and survival during cellular stress. mBio 15, e0098124 (2024).","DOI":"10.1128\/mbio.00981-24"},{"key":"93_CR169","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1128\/EC.3.5.1249-1260.2004","volume":"3","author":"PR Kraus","year":"2004","unstructured":"Kraus, P. R. et al. Identification of Cryptococcus neoformans temperature-regulated genes with a genomic-DNA microarray. Eukaryot. Cell 3, 1249\u20131260 (2004).","journal-title":"Eukaryot. Cell"},{"key":"93_CR170","doi-asserted-by":"publisher","first-page":"183136","DOI":"10.1016\/j.bbamem.2019.183136","volume":"1862","author":"P Perczyk","year":"2020","unstructured":"Perczyk, P. et al. The role of phospholipid composition and ergosterol presence in the adaptation of fungal membranes to harsh environmental conditions-membrane modeling study. Biochim Biophys. Acta Biomembr. 1862, 183136 (2020).","journal-title":"Biochim Biophys. Acta Biomembr."},{"key":"93_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1432-1327.1999.00822.x","volume":"266","author":"K Athenstaedt","year":"1999","unstructured":"Athenstaedt, K. & Daum, G. Phosphatidic acid, a key intermediate in lipid metabolism. Eur. J. Biochem 266, 1\u201316 (1999).","journal-title":"Eur. J. Biochem"},{"key":"93_CR172","doi-asserted-by":"publisher","first-page":"158907","DOI":"10.1016\/j.bbalip.2021.158907","volume":"1866","author":"K Athenstaedt","year":"2021","unstructured":"Athenstaedt, K. Phosphatidic acid biosynthesis in the model organism yeast Saccharomyces cerevisiae - a survey. Biochim Biophys. Acta Mol. Cell Biol. Lipids 1866, 158907 (2021).","journal-title":"Biochim Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"93_CR173","doi-asserted-by":"publisher","first-page":"37293","DOI":"10.1074\/jbc.R700038200","volume":"282","author":"GM Carman","year":"2007","unstructured":"Carman, G. M. & Henry, S. A. Phosphatidic acid plays a central role in the transcriptional regulation of glycerophospholipid synthesis in Saccharomyces cerevisiae. J. Biol. Chem. 282, 37293\u201337297 (2007).","journal-title":"J. Biol. Chem."},{"key":"93_CR174","doi-asserted-by":"publisher","first-page":"41710","DOI":"10.1074\/jbc.M104749200","volume":"276","author":"Z Zheng","year":"2001","unstructured":"Zheng, Z. & Zou, J. The initial step of the glycerolipid pathway: identification of glycerol 3-phosphate\/dihydroxyacetone phosphate dual substrate acyltransferases in Saccharomyces cerevisiae. J. Biol. Chem. 276, 41710\u201341716 (2001).","journal-title":"J. Biol. Chem."},{"key":"93_CR175","doi-asserted-by":"publisher","first-page":"22156","DOI":"10.1016\/S0021-9258(20)80661-9","volume":"268","author":"MM Nagiec","year":"1993","unstructured":"Nagiec, M. M. et al. A suppressor gene that enables Saccharomyces cerevisiae to grow without making sphingolipids encodes a protein that resembles an Escherichia coli fatty acyltransferase. J. Biol. Chem. 268, 22156\u201322163 (1993).","journal-title":"J. Biol. Chem."},{"key":"93_CR176","doi-asserted-by":"publisher","first-page":"30845","DOI":"10.1074\/jbc.M702719200","volume":"282","author":"M Benghezal","year":"2007","unstructured":"Benghezal, M. et al. SLC1 and SLC4 encode partially redundant acyl-coenzyme A 1-acylglycerol-3-phosphate O-acyltransferases of budding yeast. J. Biol. Chem. 282, 30845\u201330855 (2007).","journal-title":"J. Biol. Chem."},{"key":"93_CR177","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1074\/jbc.275.1.235","volume":"275","author":"K Athenstaedt","year":"2000","unstructured":"Athenstaedt, K. & Daum, G. 1-Acyldihydroxyacetone-phosphate reductase (Ayr1p) of the yeast Saccharomyces cerevisiae encoded by the open reading frame YIL124w is a major component of lipid particles. J. Biol. Chem. 275, 235\u2013240 (2000).","journal-title":"J. Biol. Chem."},{"key":"93_CR178","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1091\/mbc.e11-07-0624","volume":"23","author":"CH De Smet","year":"2012","unstructured":"De Smet, C. H. et al. The yeast acyltransferase Sct1p regulates fatty acid desaturation by competing with the desaturase Ole1p. Mol. Biol. Cell 23, 1146\u20131156 (2012).","journal-title":"Mol. Biol. Cell"},{"key":"93_CR179","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fcell.2020.00063","volume":"8","author":"NJ Blunsom","year":"2020","unstructured":"Blunsom, N. J. & Cockcroft, S. CDP-Diacylglycerol synthases (CDS): gateway to phosphatidylinositol and cardiolipin synthesis. Front Cell Dev. Biol. 8, 63 (2020).","journal-title":"Front Cell Dev. Biol."},{"key":"93_CR180","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/1873-3468.12919","volume":"592","author":"CR McMaster","year":"2018","unstructured":"McMaster, C. R. From yeast to humans - roles of the Kennedy pathway for phosphatidylcholine synthesis. FEBS Lett. 592, 1256\u20131272 (2018).","journal-title":"FEBS Lett."},{"key":"93_CR181","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1074\/jbc.M110.172296","volume":"286","author":"ML Gaspar","year":"2011","unstructured":"Gaspar, M. L. et al. Coordination of storage lipid synthesis and membrane biogenesis: evidence for cross-talk between triacylglycerol metabolism and phosphatidylinositol synthesis. J. Biol. Chem. 286, 1696\u20131708 (2011).","journal-title":"J. Biol. Chem."},{"key":"93_CR182","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1074\/jbc.271.2.789","volume":"271","author":"H Shen","year":"1996","unstructured":"Shen, H. et al. The CDS1 gene encoding CDP-diacylglycerol synthase in Saccharomyces cerevisiae is essential for cell growth. J. Biol. Chem. 271, 789\u2013795 (1996).","journal-title":"J. Biol. Chem."},{"key":"93_CR183","doi-asserted-by":"publisher","first-page":"11215","DOI":"10.1074\/jbc.272.17.11215","volume":"272","author":"H Shen","year":"1997","unstructured":"Shen, H. & Dowhan, W. Regulation of phospholipid biosynthetic enzymes by the level of CDP-diacylglycerol synthase activity. J. Biol. Chem. 272, 11215\u201311220 (1997).","journal-title":"J. Biol. Chem."},{"key":"93_CR184","doi-asserted-by":"publisher","first-page":"130053","DOI":"10.1098\/rsob.130053","volume":"3","author":"J Hayles","year":"2013","unstructured":"Hayles, J. et al. A genome-wide resource of cell cycle and cell shape genes of fission yeast. Open Biol. 3, 130053 (2013).","journal-title":"Open Biol."},{"key":"93_CR185","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nbt.1628","volume":"28","author":"DU Kim","year":"2010","unstructured":"Kim, D. U. et al. Analysis of a genome-wide set of gene deletions in the fission yeast Schizosaccharomyces pombe. Nat. Biotechnol. 28, 617\u2013623 (2010).","journal-title":"Nat. Biotechnol."},{"key":"93_CR186","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1128\/jb.154.1.304-311.1983","volume":"154","author":"AS Fischl","year":"1983","unstructured":"Fischl, A. S. & Carman, G. M. Phosphatidylinositol biosynthesis in Saccharomyces cerevisiae: purification and properties of microsome-associated phosphatidylinositol synthase. J. Bacteriol. 154, 304\u2013311 (1983).","journal-title":"J. Bacteriol."},{"key":"93_CR187","doi-asserted-by":"publisher","first-page":"103674","DOI":"10.1016\/j.fgb.2022.103674","volume":"160","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Function of the phosphatidylinositol synthase Pis1 in maintenance of endoplasmic reticulum function and pathogenicity in Candida albicans. Fungal Genet Biol. 160, 103674 (2022).","journal-title":"Fungal Genet Biol."},{"key":"93_CR188","doi-asserted-by":"crossref","unstructured":"Shaw, K. J. & Ibrahim, A. S. Fosmanogepix: A review of the first-in-class broad spectrum agent for the treatment of invasive fungal infections. J. Fungi. (Basel). 6, 239 (2020).","DOI":"10.3390\/jof6040239"},{"key":"93_CR189","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1128\/AAC.00291-11","volume":"55","author":"M Miyazaki","year":"2011","unstructured":"Miyazaki, M. et al. In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds. Antimicrob. Agents Chemother. 55, 4652\u20134658 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR190","doi-asserted-by":"publisher","first-page":"126713","DOI":"10.1016\/j.bmcl.2019.126713","volume":"29","author":"M Trzoss","year":"2019","unstructured":"Trzoss, M. et al. Synthesis of analogs of the Gwt1 inhibitor manogepix (APX001A) and in vitro evaluation against Cryptococcus spp. Bioorg. Med Chem. Lett. 29, 126713 (2019).","journal-title":"Bioorg. Med Chem. Lett."},{"key":"93_CR191","doi-asserted-by":"publisher","first-page":"7279","DOI":"10.1073\/pnas.80.23.7279","volume":"80","author":"VA Letts","year":"1983","unstructured":"Letts, V. A. et al. Isolation of the yeast structural gene for the membrane-associated enzyme phosphatidylserine synthase. Proc. Natl Acad. Sci. USA 80, 7279\u20137283 (1983).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"93_CR192","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/j.1365-2958.2009.07018.x","volume":"75","author":"YL Chen","year":"2010","unstructured":"Chen, Y. L. et al. Phosphatidylserine synthase and phosphatidylserine decarboxylase are essential for cell wall integrity and virulence in Candida albicans. Mol. Microbiol 75, 1112\u20131132 (2010).","journal-title":"Mol. Microbiol"},{"key":"93_CR193","doi-asserted-by":"publisher","first-page":"e0063324","DOI":"10.1128\/mbio.00633-24","volume":"15","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y. et al. The small molecule CBR-5884 inhibits the Candida albicans phosphatidylserine synthase. mBio 15, e0063324 (2024).","journal-title":"mBio"},{"key":"93_CR194","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1074\/jbc.RA118.006738","volume":"294","author":"P Konarzewska","year":"2019","unstructured":"Konarzewska, P. et al. Phosphatidylserine synthesis is essential for viability of the human fungal pathogen Cryptococcus neoformans. J. Biol. Chem. 294, 2329\u20132339 (2019).","journal-title":"J. Biol. Chem."},{"key":"93_CR195","doi-asserted-by":"publisher","first-page":"6062","DOI":"10.1074\/jbc.270.11.6062","volume":"270","author":"PJ Trotter","year":"1995","unstructured":"Trotter, P. J. & Voelker, D. R. Identification of a non-mitochondrial phosphatidylserine decarboxylase activity (PSD2) in the yeast Saccharomyces cerevisiae. J. Biol. Chem. 270, 6062\u20136070 (1995).","journal-title":"J. Biol. Chem."},{"key":"93_CR196","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S0005-2760(97)00101-X","volume":"1348","author":"DR Voelker","year":"1997","unstructured":"Voelker, D. R. Phosphatidylserine decarboxylase. Biochim Biophys. Acta 1348, 236\u2013244 (1997).","journal-title":"Biochim Biophys. Acta"},{"key":"93_CR197","doi-asserted-by":"publisher","first-page":"24580","DOI":"10.1016\/S0021-9258(19)74506-2","volume":"268","author":"CJ Clancey","year":"1993","unstructured":"Clancey, C. J., Chang, S. C. & Dowhan, W. Cloning of a gene (PSD1) encoding phosphatidylserine decarboxylase from Saccharomyces cerevisiae by complementation of an Escherichia coli mutant. J. Biol. Chem. 268, 24580\u201324590 (1993).","journal-title":"J. Biol. Chem."},{"key":"93_CR198","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1128\/IAI.00480-19","volume":"88","author":"RN Tams","year":"2020","unstructured":"Tams, R. N. et al. Pathways that synthesize phosphatidylethanolamine impact candida albicans hyphal length and cell wall composition through transcriptional and posttranscriptional mechanisms. Infect. Immun. 88, 3 (2020).","journal-title":"Infect. Immun."},{"key":"93_CR199","doi-asserted-by":"publisher","first-page":"15428","DOI":"10.1016\/S0021-9258(18)47744-7","volume":"262","author":"T Kodaki","year":"1987","unstructured":"Kodaki, T. & Yamashita, S. Yeast phosphatidylethanolamine methylation pathway. Cloning and characterization of two distinct methyltransferase genes. J. Biol. Chem. 262, 15428\u201315435 (1987).","journal-title":"J. Biol. Chem."},{"key":"93_CR200","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1432-1033.1989.tb15109.x","volume":"185","author":"T Kodaki","year":"1989","unstructured":"Kodaki, T. & Yamashita, S. Characterization of the methyltransferases in the yeast phosphatidylethanolamine methylation pathway by selective gene disruption. Eur. J. Biochem 185, 243\u2013251 (1989).","journal-title":"Eur. J. Biochem"},{"key":"93_CR201","doi-asserted-by":"publisher","first-page":"36588","DOI":"10.1074\/jbc.M608851200","volume":"281","author":"WR Riekhof","year":"2006","unstructured":"Riekhof, W. R. & Voelker, D. R. Uptake and utilization of lyso-phosphatidylethanolamine by Saccharomyces cerevisiae. J. Biol. Chem. 281, 36588\u201336596 (2006).","journal-title":"J. Biol. Chem."},{"key":"93_CR202","doi-asserted-by":"publisher","first-page":"36853","DOI":"10.1074\/jbc.M706718200","volume":"282","author":"WR Riekhof","year":"2007","unstructured":"Riekhof, W. R. et al. Lysophosphatidylcholine metabolism in Saccharomyces cerevisiae: the role of P-type ATPases in transport and a broad specificity acyltransferase in acylation. J. Biol. Chem. 282, 36853\u201336861 (2007).","journal-title":"J. Biol. Chem."},{"key":"93_CR203","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fmicb.2019.00086","volume":"10","author":"RN Tams","year":"2019","unstructured":"Tams, R. N. et al. Overproduction of phospholipids by the kennedy pathway leads to hypervirulence in Candida albicans. Front. Microbiol. 10, 86 (2019).","journal-title":"Front. Microbiol."},{"key":"93_CR204","doi-asserted-by":"crossref","unstructured":"Lee, C. et al. Loss of Opi3 causes a lipid imbalance that influences the virulence traits of Cryptococcus neoformans but not cryptococcosis. Front. Cell. Infect. Microbiol. 14, 1448229 (2024).","DOI":"10.3389\/fcimb.2024.1448229"},{"key":"93_CR205","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26850-3","volume":"12","author":"C Fu","year":"2021","unstructured":"Fu, C. et al. Leveraging machine learning essentiality predictions and chemogenomic interactions to identify antifungal targets. Nat. Commun. 12, 6497 (2021).","journal-title":"Nat. Commun."},{"key":"93_CR206","doi-asserted-by":"publisher","first-page":"15996","DOI":"10.1016\/S0021-9258(18)55496-X","volume":"265","author":"J Nikawa","year":"1990","unstructured":"Nikawa, J. et al. Primary structure of the yeast choline transport gene and regulation of its expression. J. Biol. Chem. 265, 15996\u201316003 (1990).","journal-title":"J. Biol. Chem."},{"key":"93_CR207","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.fgb.2018.12.010","volume":"124","author":"C Mu","year":"2019","unstructured":"Mu, C. et al. Phosphatidate phosphatase Pah1 has a role in the hyphal growth and virulence of Candida albicans. Fungal Genet Biol. 124, 47\u201358 (2019).","journal-title":"Fungal Genet Biol."},{"key":"93_CR208","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18028-0","volume":"11","author":"JH Jin","year":"2020","unstructured":"Jin, J. H. et al. Genome-wide functional analysis of phosphatases in the pathogenic fungus Cryptococcus neoformans. Nat. Commun. 11, 4212 (2020).","journal-title":"Nat. Commun."},{"key":"93_CR209","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1091\/mbc.12.4.997","volume":"12","author":"R Birner","year":"2001","unstructured":"Birner, R. et al. Roles of phosphatidylethanolamine and of its several biosynthetic pathways in Saccharomyces cerevisiae. Mol. Biol. Cell 12, 997\u20131007 (2001).","journal-title":"Mol. Biol. Cell"},{"key":"93_CR210","doi-asserted-by":"publisher","first-page":"14857","DOI":"10.1074\/jbc.274.21.14857","volume":"274","author":"K Kim","year":"1999","unstructured":"Kim, K. et al. Isolation and characterization of the Saccharomyces cerevisiae EKI1 gene encoding ethanolamine kinase. J. Biol. Chem. 274, 14857\u201314866 (1999).","journal-title":"J. Biol. Chem."},{"key":"93_CR211","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1074\/jbc.M003694200","volume":"276","author":"SR Dowd","year":"2001","unstructured":"Dowd, S. R., Bier, M. E. & Patton-Vogt, J. L. Turnover of phosphatidylcholine in Saccharomyces cerevisiae. The role of the CDP-choline pathway. J. Biol. Chem. 276, 3756\u20133763 (2001).","journal-title":"J. Biol. Chem."},{"key":"93_CR212","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1093\/oxfordjournals.jbchem.a021497","volume":"120","author":"R Min-Seok","year":"1996","unstructured":"Min-Seok, R. et al. Isolation and characterization of ECT1 gene encoding CTP: phosphoethanolamine cytidylyltransferase of Saccharomyces cerevisiae. J. Biochem 120, 1040\u20131047 (1996).","journal-title":"J. Biochem"},{"key":"93_CR213","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1006\/prep.2000.1354","volume":"21","author":"JA Friesen","year":"2001","unstructured":"Friesen, J. A., Park, Y. S. & Kent, C. Purification and kinetic characterization of CTP:phosphocholine cytidylyltransferase from Saccharomyces cerevisiae. Protein Expr. Purif. 21, 141\u2013148 (2001).","journal-title":"Protein Expr. Purif."},{"key":"93_CR214","doi-asserted-by":"publisher","first-page":"19748","DOI":"10.1016\/S0021-9258(19)77698-4","volume":"263","author":"RH Hjelmstad","year":"1988","unstructured":"Hjelmstad, R. H. & Bell, R. M. The sn-1,2-diacylglycerol ethanolaminephosphotransferase activity of Saccharomyces cerevisiae. Isolation of mutants and cloning of the EPT1 gene. J. Biol. Chem. 263, 19748\u201319757 (1988).","journal-title":"J. Biol. Chem."},{"key":"93_CR215","doi-asserted-by":"publisher","first-page":"28769","DOI":"10.1016\/S0021-9258(19)61972-1","volume":"269","author":"SC Morash","year":"1994","unstructured":"Morash, S. C. et al. Studies employing Saccharomyces cerevisiae cpt1 and ept1 null mutants implicate the CPT1 gene in coordinate regulation of phospholipid biosynthesis. J. Biol. Chem. 269, 28769\u201328776 (1994).","journal-title":"J. Biol. Chem."},{"key":"93_CR216","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1099\/jmm.0.000019","volume":"64","author":"F Compain","year":"2015","unstructured":"Compain, F. et al. In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp. J. Med Microbiol 64, 309\u2013311 (2015).","journal-title":"J. Med Microbiol"},{"key":"93_CR217","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3389\/fmicb.2020.00854","volume":"11","author":"Y Wu","year":"2020","unstructured":"Wu, Y. et al. Antifungal activity and mode of action of miltefosine against clinical isolates of Candida krusei. Front. Microbiol. 11, 854 (2020).","journal-title":"Front. Microbiol."},{"key":"93_CR218","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.2147\/IJN.S205350","volume":"14","author":"CC Spadari","year":"2019","unstructured":"Spadari, C. C. et al. Alginate nanoparticles as non-toxic delivery system for miltefosine in the treatment of candidiasis and cryptococcosis. Int. J. Nanomed. 14, 5187\u20135199 (2019).","journal-title":"Int. J. Nanomed."},{"key":"93_CR219","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1099\/jmm.0.000041","volume":"64","author":"LP Borba-Santos","year":"2015","unstructured":"Borba-Santos, L. P. et al. Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole. J. Med. Microbiol. 64, 415\u2013422 (2015).","journal-title":"J. Med. Microbiol."},{"key":"93_CR220","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/jam.12891","volume":"119","author":"RS Brilhante","year":"2015","unstructured":"Brilhante, R. S. et al. In vitro antifungal activity of miltefosine and levamisole: their impact on ergosterol biosynthesis and cell permeability of dimorphic fungi. J. Appl. Microbiol. 119, 962\u2013969 (2015).","journal-title":"J. Appl. Microbiol."},{"key":"93_CR221","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1093\/mmy\/myt027","volume":"52","author":"RS Brilhante","year":"2014","unstructured":"Brilhante, R. S. et al. In vitro inhibitory effect of miltefosine against strains of Histoplasma capsulatum var. capsulatum and Sporothrix spp. Med. Mycol. 52, 320\u2013325 (2014).","journal-title":"Med. Mycol."},{"key":"93_CR222","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/mmy\/myy119","volume":"57","author":"RSN Brilhante","year":"2019","unstructured":"Brilhante, R. S. N. et al. Potassium iodide and miltefosine inhibit biofilms of Sporothrix schenckii species complex in yeast and filamentous forms. Med. Mycol. 57, 764\u2013772 (2019).","journal-title":"Med. Mycol."},{"key":"93_CR223","doi-asserted-by":"publisher","first-page":"6996","DOI":"10.1128\/AAC.03212-14","volume":"58","author":"S Imbert","year":"2014","unstructured":"Imbert, S. et al. In vitro combination of voriconazole and miltefosine against clinically relevant molds. Antimicrob. Agents Chemother. 58, 6996\u20136998 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR224","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1086\/597772","volume":"48","author":"AM Kesson","year":"2009","unstructured":"Kesson, A. M. et al. Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report. Clin. Infect. Dis. 48, 1257\u20131261 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"93_CR225","doi-asserted-by":"crossref","unstructured":"Loreto, E. S. et al. In vitro activities of miltefosine and antibacterial agents from the macrolide, oxazolidinone, and pleuromutilin classes against pythium insidiosum and pythium aphanidermatum. Antimicrob. Agents Chemother. 82, e01678\u201317 (2018).","DOI":"10.1128\/AAC.01678-17"},{"key":"93_CR226","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.ijantimicag.2016.12.020","volume":"49","author":"DCP Rossi","year":"2017","unstructured":"Rossi, D. C. P. et al. Miltefosine is fungicidal to Paracoccidioides spp. yeast cells but subinhibitory concentrations induce melanisation. Int J. Antimicrob. Agents 49, 465\u2013471 (2017).","journal-title":"Int J. Antimicrob. Agents"},{"key":"93_CR227","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1128\/AAC.01382-06","volume":"51","author":"Z Tong","year":"2007","unstructured":"Tong, Z. et al. In vitro activities of miltefosine and two novel antifungal biscationic salts against a panel of 77 dermatophytes. Antimicrob. Agents Chemother. 51, 2219\u20132222 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR228","doi-asserted-by":"publisher","first-page":"7899","DOI":"10.1073\/pnas.91.17.7899","volume":"91","author":"MM Nagiec","year":"1994","unstructured":"Nagiec, M. M. et al. The LCB2 gene of Saccharomyces and the related LCB1 gene encode subunits of serine palmitoyltransferase, the initial enzyme in sphingolipid synthesis. Proc. Natl Acad. Sci. USA 91, 7899\u20137902 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"93_CR229","doi-asserted-by":"publisher","first-page":"20453","DOI":"10.1074\/jbc.M113.472860","volume":"288","author":"C Gururaj","year":"2013","unstructured":"Gururaj, C., Federman, R. S. & Chang, A. Orm proteins integrate multiple signals to maintain sphingolipid homeostasis. J. Biol. Chem. 288, 20453\u201320463 (2013).","journal-title":"J. Biol. Chem."},{"key":"93_CR230","doi-asserted-by":"publisher","first-page":"7597","DOI":"10.1074\/jbc.275.11.7597","volume":"275","author":"K Gable","year":"2000","unstructured":"Gable, K. et al. Tsc3p is an 80-amino acid protein associated with serine palmitoyltransferase and required for optimal enzyme activity. J. Biol. Chem. 275, 7597\u20137603 (2000).","journal-title":"J. Biol. Chem."},{"key":"93_CR231","doi-asserted-by":"publisher","first-page":"30688","DOI":"10.1074\/jbc.273.46.30688","volume":"273","author":"T Beeler","year":"1998","unstructured":"Beeler, T. et al. The Saccharomyces cerevisiae TSC10\/YBR265w gene encoding 3-ketosphinganine reductase is identified in a screen for temperature-sensitive suppressors of the Ca2\u2009+\u2009-sensitive csg2Delta mutant. J. Biol. Chem. 273, 30688\u201330694 (1998).","journal-title":"J. Biol. Chem."},{"key":"93_CR232","doi-asserted-by":"publisher","first-page":"11062","DOI":"10.1074\/jbc.273.18.11062","volume":"273","author":"MM Grilley","year":"1998","unstructured":"Grilley, M. M. et al. Syringomycin action gene SYR2 is essential for sphingolipid 4-hydroxylation in Saccharomyces cerevisiae. J. Biol. Chem. 273, 11062\u201311068 (1998).","journal-title":"J. Biol. Chem."},{"key":"93_CR233","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12866-015-0588-0","volume":"15","author":"F Perdoni","year":"2015","unstructured":"Perdoni, F. et al. Antifungal activity of Myriocin on clinically relevant Aspergillus fumigatus strains producing biofilm. BMC Microbiol 15, 248 (2015).","journal-title":"BMC Microbiol"},{"key":"93_CR234","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ja.2015.11","volume":"68","author":"CB Pereira","year":"2015","unstructured":"Pereira, C. B. et al. Endophytic fungal compounds active against Cryptococcus neoformans and C. gattii. J. Antibiot. 68, 436\u2013444 (2015).","journal-title":"J. Antibiot."},{"key":"93_CR235","doi-asserted-by":"publisher","first-page":"14276","DOI":"10.1021\/ja4059876","volume":"135","author":"JM Wadsworth","year":"2013","unstructured":"Wadsworth, J. M. et al. The chemical basis of serine palmitoyltransferase inhibition by myriocin. J. Am. Chem. Soc. 135, 14276\u201314285 (2013).","journal-title":"J. Am. Chem. Soc."},{"key":"93_CR236","doi-asserted-by":"publisher","first-page":"25032","DOI":"10.1016\/S0021-9258(19)74001-0","volume":"267","author":"MM Zweerink","year":"1992","unstructured":"Zweerink, M. M. et al. Characterization of a novel, potent, and specific inhibitor of serine palmitoyltransferase. J. Biol. Chem. 267, 25032\u201325038 (1992).","journal-title":"J. Biol. Chem."},{"key":"93_CR237","doi-asserted-by":"publisher","first-page":"861","DOI":"10.7164\/antibiotics.45.861","volume":"45","author":"F VanMiddlesworth","year":"1992","unstructured":"VanMiddlesworth, F. et al. Sphingofungins A, B, C, and D; a new family of antifungal agents. I. Fermentation, isolation, and biological activity. J. Antibiot. (Tokyo) 45, 861\u2013867 (1992).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"93_CR238","doi-asserted-by":"crossref","unstructured":"Limar, S. et al. Yeast Svf1 binds ceramides and contributes to sphingolipid metabolism at the ER cis-Golgi interface. J. Cell Biol. 222, e202109162 (2023).","DOI":"10.1083\/jcb.202109162"},{"key":"93_CR239","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1128\/AAC.43.2.371","volume":"43","author":"AJ De Lucca","year":"1999","unstructured":"De Lucca, A. J. et al. Fungal lethality, binding, and cytotoxicity of syringomycin-E. Antimicrob. Agents Chemother. 43, 371\u2013373 (1999).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR240","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1091\/mbc.12.11.3417","volume":"12","author":"S Schorling","year":"2001","unstructured":"Schorling, S. et al. Lag1p and Lac1p are essential for the Acyl-CoA-dependent ceramide synthase reaction in Saccharomyces cerevisae. Mol. Biol. Cell 12, 3417\u20133427 (2001).","journal-title":"Mol. Biol. Cell"},{"key":"93_CR241","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/sj.emboj.7600562","volume":"24","author":"B Vallee","year":"2005","unstructured":"Vallee, B. & Riezman, H. Lip1p: a novel subunit of acyl-CoA ceramide synthase. EMBO J. 24, 730\u2013741 (2005).","journal-title":"EMBO J."},{"key":"93_CR242","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.celrep.2018.01.035","volume":"22","author":"MA Munshi","year":"2018","unstructured":"Munshi, M. A. et al. The role of ceramide synthases in the pathogenicity of Cryptococcus neoformans. Cell Rep. 22, 1392\u20131400 (2018).","journal-title":"Cell Rep."},{"key":"93_CR243","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/(SICI)1097-0061(19980315)14:4<311::AID-YEA220>3.0.CO;2-B","volume":"14","author":"TM Dunn","year":"1998","unstructured":"Dunn, T. M. et al. Synthesis of monohydroxylated inositolphosphorylceramide (IPC-C) in Saccharomyces cerevisiae requires Scs7p, a protein with both a cytochrome b5-like domain and a hydroxylase\/desaturase domain. Yeast 14, 311\u2013321 (1998).","journal-title":"Yeast"},{"key":"93_CR244","first-page":"236","volume":"251","author":"T Hashida-Okado","year":"1996","unstructured":"Hashida-Okado, T. et al. AUR1, a novel gene conferring aureobasidin resistance on Saccharomyces cerevisiae: a study of defective morphologies in Aur1p-depleted cells. Mol. Gen. Genet 251, 236\u2013244 (1996).","journal-title":"Mol. Gen. Genet"},{"key":"93_CR245","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1128\/AAC.39.12.2765","volume":"39","author":"SA Heidler","year":"1995","unstructured":"Heidler, S. A. & Radding, J. A. The AUR1 gene in Saccharomyces cerevisiae encodes dominant resistance to the antifungal agent aureobasidin A (LY295337). Antimicrob. Agents Chemother. 39, 2765\u20132769 (1995).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR246","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s004380050530","volume":"255","author":"TJ Beeler","year":"1997","unstructured":"Beeler, T. J. et al. SUR1 (CSG1\/BCL21), a gene necessary for growth of Saccharomyces cerevisiae in the presence of high Ca2+ concentrations at 37 degrees C, is required for mannosylation of inositolphosphorylceramide. Mol. Gen. Genet 255, 570\u2013579 (1997).","journal-title":"Mol. Gen. Genet"},{"key":"93_CR247","doi-asserted-by":"publisher","first-page":"45049","DOI":"10.1074\/jbc.M305498200","volume":"278","author":"S Uemura","year":"2003","unstructured":"Uemura, S. et al. Csg1p and newly identified Csh1p function in mannosylinositol phosphorylceramide synthesis by interacting with Csg2p. J. Biol. Chem. 278, 45049\u201345055 (2003).","journal-title":"J. Biol. Chem."},{"key":"93_CR248","doi-asserted-by":"publisher","first-page":"29620","DOI":"10.1074\/jbc.272.47.29620","volume":"272","author":"RC Dickson","year":"1997","unstructured":"Dickson, R. C. et al. Synthesis of mannose-(inositol-P)2-ceramide, the major sphingolipid in Saccharomyces cerevisiae, requires the IPT1 (YDR072c) gene. J. Biol. Chem. 272, 29620\u201329625 (1997).","journal-title":"J. Biol. Chem."},{"key":"93_CR249","doi-asserted-by":"publisher","first-page":"39793","DOI":"10.1074\/jbc.M007721200","volume":"275","author":"H Sawai","year":"2000","unstructured":"Sawai, H. et al. Identification of ISC1 (YER019w) as inositol phosphosphingolipid phospholipase C in Saccharomyces cerevisiae. J. Biol. Chem. 275, 39793\u201339798 (2000).","journal-title":"J. Biol. Chem."},{"key":"93_CR250","doi-asserted-by":"publisher","first-page":"6876","DOI":"10.1074\/jbc.275.10.6876","volume":"275","author":"C Mao","year":"2000","unstructured":"Mao, C. et al. Cloning of an alkaline ceramidase from Saccharomyces cerevisiae. An enzyme with reverse (CoA-independent) ceramide synthase activity. J. Biol. Chem. 275, 6876\u20136884 (2000).","journal-title":"J. Biol. Chem."},{"key":"93_CR251","doi-asserted-by":"publisher","first-page":"31369","DOI":"10.1074\/jbc.M003683200","volume":"275","author":"C Mao","year":"2000","unstructured":"Mao, C. et al. Cloning and characterization of a Saccharomyces cerevisiae alkaline ceramidase with specificity for dihydroceramide. J. Biol. Chem. 275, 31369\u201331378 (2000).","journal-title":"J. Biol. Chem."},{"key":"93_CR252","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1128\/AAC.44.3.651-653.2000","volume":"44","author":"W Zhong","year":"2000","unstructured":"Zhong, W., Jeffries, M. W. & Georgopapadakou, N. H. Inhibition of inositol phosphorylceramide synthase by aureobasidin A in Candida and Aspergillus species. Antimicrob. Agents Chemother. 44, 651\u2013653 (2000).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR253","doi-asserted-by":"publisher","first-page":"27299","DOI":"10.1016\/S0021-9258(19)74249-5","volume":"268","author":"AH Merrill Jr.","year":"1993","unstructured":"Merrill, A. H. Jr. et al. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. J. Biol. Chem. 268, 27299\u201327306 (1993).","journal-title":"J. Biol. Chem."},{"key":"93_CR254","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1177\/0960327108099525","volume":"27","author":"H Stockmann-Juvala","year":"2008","unstructured":"Stockmann-Juvala, H. & Savolainen, K. A review of the toxic effects and mechanisms of action of fumonisin B1. Hum. Exp. Toxicol. 27, 799\u2013809 (2008).","journal-title":"Hum. Exp. Toxicol."},{"key":"93_CR255","doi-asserted-by":"crossref","unstructured":"McEvoy, K., Normile, T. G. & Del Poeta, M. Antifungal drug development: targeting the fungal sphingolipid pathway. J. Fungi. (Basel). 6, 142 (2020).","DOI":"10.3390\/jof6030142"},{"key":"93_CR256","doi-asserted-by":"publisher","first-page":"111977","DOI":"10.1016\/j.fct.2021.111977","volume":"149","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. Fumonisin B(1): Mechanisms of toxicity and biological detoxification progress in animals. Food Chem. Toxicol. 149, 111977 (2021).","journal-title":"Food Chem. Toxicol."},{"key":"93_CR257","doi-asserted-by":"publisher","first-page":"14942","DOI":"10.1074\/jbc.273.24.14942","volume":"273","author":"SM Mandala","year":"1998","unstructured":"Mandala, S. M. et al. Rustmicin, a potent antifungal agent, inhibits sphingolipid synthesis at inositol phosphoceramide synthase. J. Biol. Chem. 273, 14942\u201314949 (1998).","journal-title":"J. Biol. Chem."},{"key":"93_CR258","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1128\/IAI.00768-06","volume":"74","author":"JM Shea","year":"2006","unstructured":"Shea, J. M. et al. The cryptococcal enzyme inositol phosphosphingolipid-phospholipase C confers resistance to the antifungal effects of macrophages and promotes fungal dissemination to the central nervous system. Infect. Immun. 74, 5977\u20135988 (2006).","journal-title":"Infect. Immun."},{"key":"93_CR259","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/mmi.13474","volume":"102","author":"CM Fernandes","year":"2016","unstructured":"Fernandes, C. M. et al. Functional characterization of the Aspergillus nidulans glucosylceramide pathway reveals that LCB Delta8-desaturation and C9-methylation are relevant to filamentous growth, lipid raft localization and Psd1 defensin activity. Mol. Microbiol 102, 488\u2013505 (2016).","journal-title":"Mol. Microbiol"},{"key":"93_CR260","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0014-5793(02)03067-3","volume":"525","author":"SB Levery","year":"2002","unstructured":"Levery, S. B. et al. Disruption of the glucosylceramide biosynthetic pathway in Aspergillus nidulans and Aspergillus fumigatus by inhibitors of UDP-Glc:ceramide glucosyltransferase strongly affects spore germination, cell cycle, and hyphal growth. FEBS Lett. 525, 59\u201364 (2002).","journal-title":"FEBS Lett."},{"key":"93_CR261","doi-asserted-by":"publisher","first-page":"e1003832","DOI":"10.1371\/journal.ppat.1003832","volume":"10","author":"M Del Poeta","year":"2014","unstructured":"Del Poeta, M. et al. Synthesis and biological properties of fungal glucosylceramide. PLoS Pathog. 10, e1003832 (2014).","journal-title":"PLoS Pathog."},{"key":"93_CR262","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1099\/mic.0.2008\/018788-0","volume":"154","author":"T Oura","year":"2008","unstructured":"Oura, T. & Kajiwara, S. Disruption of the sphingolipid delta8-desaturase gene causes a delay in morphological changes in Candida albicans. Microbiol. (Read.) 154, 3795\u20133803 (2008).","journal-title":"Microbiol. (Read.)"},{"key":"93_CR263","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/ng.605","volume":"42","author":"SM Noble","year":"2010","unstructured":"Noble, S. M. et al. Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity. Nat. Genet 42, 590\u2013598 (2010).","journal-title":"Nat. Genet"},{"key":"93_CR264","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.1462-5822.2011.01735.x","volume":"14","author":"A Singh","year":"2012","unstructured":"Singh, A. et al. Methylation of glycosylated sphingolipid modulates membrane lipid topography and pathogenicity of Cryptococcus neoformans. Cell Microbiol 14, 500\u2013516 (2012).","journal-title":"Cell Microbiol"},{"key":"93_CR265","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/j.bbamem.2017.08.017","volume":"1859","author":"S Raj","year":"2017","unstructured":"Raj, S. et al. Changes in glucosylceramide structure affect virulence and membrane biophysical properties of Cryptococcus neoformans. Biochim Biophys. Acta Biomembr. 1859, 2224\u20132233 (2017).","journal-title":"Biochim Biophys. Acta Biomembr."},{"key":"93_CR266","doi-asserted-by":"crossref","unstructured":"Mor, V. et al. Erratum for Mor et al. \u201cIdentification of a new class of antifungals targeting the synthesis of fungal sphingolipids\u201d. mBio 9, e00188\u201318 (2018).","DOI":"10.1128\/mBio.00188-18"},{"key":"93_CR267","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1128\/EC.00008-07","volume":"6","author":"FJ Alvarez","year":"2007","unstructured":"Alvarez, F. J., Douglas, L. M. & Konopka, J. B. Sterol-rich plasma membrane domains in fungi. Eukaryot. Cell 6, 755\u2013763 (2007).","journal-title":"Eukaryot. Cell"},{"key":"93_CR268","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1529\/biophysj.106.085480","volume":"91","author":"V Shahedi","year":"2006","unstructured":"Shahedi, V., Oradd, G. & Lindblom, G. Domain-formation in DOPC\/SM bilayers studied by pfg-NMR: effect of sterol structure. Biophys. J. 91, 2501\u20132507 (2006).","journal-title":"Biophys. J."},{"key":"93_CR269","doi-asserted-by":"publisher","first-page":"158815","DOI":"10.1016\/j.bbalip.2020.158815","volume":"1866","author":"M Kumar","year":"2021","unstructured":"Kumar, M. et al. Sphingolipidomics of drug resistant Candida auris clinical isolates reveal distinct sphingolipid species signatures. Biochim Biophys. Acta Mol. Cell Biol. Lipids 1866, 158815 (2021).","journal-title":"Biochim Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"93_CR270","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1016\/j.bbamem.2018.05.016","volume":"1860","author":"NK Khandelwal","year":"2018","unstructured":"Khandelwal, N. K. et al. Phosphatidylserine decarboxylase governs plasma membrane fluidity and impacts drug susceptibilities of Candida albicans cells. Biochim Biophys. Acta Biomembr. 1860, 2308\u20132319 (2018).","journal-title":"Biochim Biophys. Acta Biomembr."},{"key":"93_CR271","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06944-1","volume":"9","author":"J Gao","year":"2018","unstructured":"Gao, J. et al. Candida albicans gains azole resistance by altering sphingolipid composition. Nat. Commun. 9, 4495 (2018).","journal-title":"Nat. Commun."},{"key":"93_CR272","doi-asserted-by":"publisher","first-page":"e13092","DOI":"10.1111\/cmi.13092","volume":"21","author":"P Zhai","year":"2019","unstructured":"Zhai, P. et al. A sphingolipid synthesis-related protein OrmA in Aspergillus fumigatus is responsible for azole susceptibility and virulence. Cell Microbiol 21, e13092 (2019).","journal-title":"Cell Microbiol"},{"key":"93_CR273","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1128\/AAC.05106-11","volume":"56","author":"D Vandenbosch","year":"2012","unstructured":"Vandenbosch, D. et al. Phytosphingosine-1-phosphate is a signaling molecule involved in miconazole resistance in sessile Candida albicans cells. Antimicrob. Agents Chemother. 56, 2290\u20132294 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR274","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s12223-019-00713-3","volume":"65","author":"D Kundu","year":"2020","unstructured":"Kundu, D. et al. Phospholipid biosynthesis disruption renders the yeast cells sensitive to antifungals. Folia Microbiol (Praha) 65, 121\u2013131 (2020).","journal-title":"Folia Microbiol (Praha)"},{"key":"93_CR275","first-page":"171","volume":"313","author":"AH Tong","year":"2006","unstructured":"Tong, A. H. & Boone, C. Synthetic genetic array analysis in Saccharomyces cerevisiae. Methods Mol. Biol. 313, 171\u2013192 (2006).","journal-title":"Methods Mol. Biol."},{"key":"93_CR276","doi-asserted-by":"publisher","first-page":"16653","DOI":"10.1073\/pnas.0806261105","volume":"105","author":"SJ Dixon","year":"2008","unstructured":"Dixon, S. J. et al. Significant conservation of synthetic lethal genetic interaction networks between distantly related eukaryotes. Proc. Natl Acad. Sci. USA 105, 16653\u201316658 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"93_CR277","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4161\/cib.7501","volume":"2","author":"SJ Dixon","year":"2009","unstructured":"Dixon, S. J., Andrews, B. J. & Boone, C. Exploring the conservation of synthetic lethal genetic interaction networks. Commun. Integr. Biol. 2, 78\u201381 (2009).","journal-title":"Commun. Integr. Biol."},{"key":"93_CR278","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nbt919","volume":"22","author":"AB Parsons","year":"2004","unstructured":"Parsons, A. B. et al. Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat. Biotechnol. 22, 62\u201369 (2004).","journal-title":"Nat. Biotechnol."},{"key":"93_CR279","doi-asserted-by":"publisher","first-page":"12123","DOI":"10.1073\/pnas.0505482102","volume":"102","author":"JP Miller","year":"2005","unstructured":"Miller, J. P. et al. Large-scale identification of yeast integral membrane protein interactions. Proc. Natl Acad. Sci. USA 102, 12123\u201312128 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"93_CR280","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1126\/science.1153878","volume":"320","author":"K Tarassov","year":"2008","unstructured":"Tarassov, K. et al. An in vivo map of the yeast protein interactome. Science 320, 1465\u20131470 (2008).","journal-title":"Science"},{"key":"93_CR281","doi-asserted-by":"crossref","unstructured":"Huang, L. J. & Chen, R. H. Lipid saturation induces degradation of squalene epoxidase for sterol homeostasis and cell survival. Life Sci. Alliance 6, e202201612 (2023).","DOI":"10.26508\/lsa.202201612"},{"key":"93_CR282","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/msb.2010.107","volume":"6","author":"L Kapitzky","year":"2010","unstructured":"Kapitzky, L. et al. Cross-species chemogenomic profiling reveals evolutionarily conserved drug mode of action. Mol. Syst. Biol. 6, 451 (2010).","journal-title":"Mol. Syst. Biol."},{"key":"93_CR283","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.micres.2013.11.004","volume":"169","author":"D Hoepfner","year":"2014","unstructured":"Hoepfner, D. et al. High-resolution chemical dissection of a model eukaryote reveals targets, pathways and gene functions. Microbiol Res 169, 107\u2013120 (2014).","journal-title":"Microbiol Res"},{"key":"93_CR284","doi-asserted-by":"publisher","first-page":"104998","DOI":"10.1016\/j.tiv.2020.104998","volume":"69","author":"M Guan","year":"2020","unstructured":"Guan, M. et al. Molecular fingerprints of conazoles via functional genomic profiling of Saccharomyces cerevisiae. Toxicol. Vitr. 69, 104998 (2020).","journal-title":"Toxicol. Vitr."},{"key":"93_CR285","doi-asserted-by":"publisher","first-page":"1101553","DOI":"10.3389\/fphar.2022.1101553","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang, H. et al. Myriocin enhances the antifungal activity of fluconazole by blocking the membrane localization of the efflux pump Cdr1. Front Pharm. 13, 1101553 (2022).","journal-title":"Front Pharm."},{"key":"93_CR286","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37573-y","volume":"14","author":"TF Dos Reis","year":"2023","unstructured":"Dos Reis, T. F. et al. A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungi. Nat. Commun. 14, 2052 (2023).","journal-title":"Nat. Commun."},{"key":"93_CR287","doi-asserted-by":"publisher","first-page":"e0103124","DOI":"10.1128\/mbio.01031-24","volume":"15","author":"C Diehl","year":"2024","unstructured":"Diehl, C. et al. Brilacidin, a novel antifungal agent against Cryptococcus neoformans. mBio 15, e0103124 (2024).","journal-title":"mBio"},{"key":"93_CR288","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1042\/bj2300765","volume":"230","author":"NS Ryder","year":"1985","unstructured":"Ryder, N. S. & Dupont, M. C. Inhibition of squalene epoxidase by allylamine antimycotic compounds. A comparative study of the fungal and mammalian enzymes. Biochem J. 230, 765\u2013770 (1985).","journal-title":"Biochem J."},{"key":"93_CR289","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1749-6632.1988.tb40405.x","volume":"544","author":"NS Ryder","year":"1988","unstructured":"Ryder, N. S. Mechanism of action and biochemical selectivity of allylamine antimycotic agents. Ann. N. Y Acad. Sci. 544, 208\u2013220 (1988).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"93_CR290","first-page":"179","volume":"10","author":"SF Kowalsky","year":"1991","unstructured":"Kowalsky, S. F. & Dixon, D. M. Fluconazole: a new antifungal agent. Clin. Pharm. 10, 179\u2013194 (1991).","journal-title":"Clin. Pharm."},{"key":"93_CR291","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1128\/AAC.41.4.841","volume":"41","author":"SA Radford","year":"1997","unstructured":"Radford, S. A., Johnson, E. M. & Warnock, D. W. In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens. Antimicrob. Agents Chemother. 41, 841\u2013843 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"93_CR292","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1345\/aph.1C261","volume":"37","author":"MM Pearson","year":"2003","unstructured":"Pearson, M. M. et al. Voriconazole: a new triazole antifungal agent. Ann. Pharmacother. 37, 420\u2013432 (2003).","journal-title":"Ann. Pharmacother."},{"key":"93_CR293","doi-asserted-by":"publisher","first-page":"349","DOI":"10.7164\/antibiotics.48.349","volume":"48","author":"SM Mandala","year":"1995","unstructured":"Mandala, S. M. et al. The discovery of australifungin, a novel inhibitor of sphinganine N-acyltransferase from Sporormiella australis. Producing organism, fermentation, isolation, and biological activity. J. Antibiot. (Tokyo) 48, 349\u2013356 (1995).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"93_CR294","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbalip.2012.07.002","volume":"1831","author":"KA Orr Gandy","year":"2013","unstructured":"Orr Gandy, K. A. & Obeid, L. M. Targeting the sphingosine kinase\/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors. Biochim. Biophys. Acta 1831, 157\u2013166 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"93_CR295","doi-asserted-by":"publisher","first-page":"627917","DOI":"10.3389\/fcimb.2021.627917","volume":"11","author":"LQ Wei","year":"2021","unstructured":"Wei, L. Q. et al. Fingolimod potentiates the antifungal activity of amphotericin B. Front Cell Infect. Microbiol. 11, 627917 (2021).","journal-title":"Front Cell Infect. Microbiol."}],"container-title":["npj Antimicrobials and Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44259-025-00093-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44259-025-00093-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44259-025-00093-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T17:01:16Z","timestamp":1744477276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44259-025-00093-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,12]]},"references-count":295,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["93"],"URL":"https:\/\/doi.org\/10.1038\/s44259-025-00093-4","relation":{},"ISSN":["2731-8745"],"issn-type":[{"value":"2731-8745","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,12]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}